<SEC-DOCUMENT>0001193125-21-167916.txt : 20210520
<SEC-HEADER>0001193125-21-167916.hdr.sgml : 20210520
<ACCEPTANCE-DATETIME>20210520170208
ACCESSION NUMBER:		0001193125-21-167916
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210519
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210520
DATE AS OF CHANGE:		20210520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REINSURANCE GROUP OF AMERICA INC
		CENTRAL INDEX KEY:			0000898174
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		IRS NUMBER:				431627032
		STATE OF INCORPORATION:			MO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11848
		FILM NUMBER:		21945282

	BUSINESS ADDRESS:	
		STREET 1:		16600 SWINGLEY RIDGE ROAD
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63017
		BUSINESS PHONE:		6367367000

	MAIL ADDRESS:	
		STREET 1:		16600 SWINGLEY RIDGE ROAD
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63017
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d173454d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rga="http://www.rgare.com/20210519" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2021-05-19_to_2021-05-19">REINSURANCE GROUP OF AMERICA INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-05-19_to_2021-05-19">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-05-19_to_2021-05-19">0000898174</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="rga-20210519.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-05-19_to_2021-05-19"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000898174</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-19</xbrli:startDate> <xbrli:endDate>2021-05-19</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000898174</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-19</xbrli:startDate> <xbrli:endDate>2021-05-19</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000898174</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rga:M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-19</xbrli:startDate> <xbrli:endDate>2021-05-19</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000898174</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rga:M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-19</xbrli:startDate> <xbrli:endDate>2021-05-19</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-05-19_to_2021-05-19">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt:datemonthdayyearen">May 19, 2021</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">REINSURANCE GROUP OF AMERICA, INCORPORATED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt-sec:stateprovnameen">Missouri</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-05-19_to_2021-05-19">1-11848</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-05-19_to_2021-05-19">43-1627032</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-05-19_to_2021-05-19">16600 Swingley Ridge Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-05-19_to_2021-05-19">Chesterfield</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt-sec:stateprovnameen">Missouri</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-05-19_to_2021-05-19">63017</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, and Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-05-19_to_2021-05-19">(636)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-05-19_to_2021-05-19">736-7000</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic">see </span>General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, par value $0.01</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">RGA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member">6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member">RZA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member">5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member">RZB</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter):</p> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-05-19_to_2021-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric>&#160;&#160;Emerging growth company</p> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#9744;&#160;&#160;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;19, 2021, at the 2021 annual meeting of shareholders (the &#8220;Annual Meeting&#8221;), the shareholders of Reinsurance Group of America, Incorporated (the &#8220;Company&#8221;), upon recommendation of the Board of Directors, approved (i)&#160;amendments to the Company&#8217;s Flexible Stock Plan (the &#8220;Flexible Stock Plan&#8221;), (ii) amendments to the Company&#8217;s Flexible Stock Plan for Directors (the &#8220;Director Plan&#8221;) and (iii)&#160;the amendment and restatement of the Company&#8217;s Phantom Stock Plan for Directors (the &#8220;Phantom Plan&#8221; and together with the Flexible Stock Plan and the Director Plan, collectively, the &#8220;Equity Plans&#8221;)). Among other things, the amendments increase the number of shares authorized for issuance as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:73%"></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-style:italic">Plan</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-style:italic">Share&#160;increase</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-style:italic">Total&#160;shares&#160;available</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Flexible Stock Plan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,460,077</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director Plan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">307,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Phantom Plan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">155,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Phantom Plan now also allows directors to receive dividend equivalent payments or dividend credit rights on the performance units held and accumulated in such director&#8217;s Phantom Plan account. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amendments to the Equity Plans will not affect any award previously made to the chief executive officer, the chief financial officer or any other named executive officer of the Company under the Equity Plans, nor under any other compensatory plan, contract or arrangement covering any such person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Equity Plans, as proposed to be amended, are described in greater detail in proposals four, five and six on pages 91 through 101 in the Company&#8217;s Proxy Statement, dated April&#160;8, 2021, for the Annual Meeting (&#8220;Proxy Statement&#8221;) filed with the Securities and Exchange Commission on that date. The descriptions of the amendments to the Equity Plans contained herein and in the Proxy Statement are qualified in their entirety by reference to the full text of the Flexible Stock Plan amendments, the Director Plan amendments and the Phantom Plan (as amended and restated), copies of which are filed as Exhibits 10.1, 10.2 and 10.3, respectively, hereto. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.07</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s Annual Meeting of Shareholders was held on May&#160;19,&#160;2021. The number of shares of common stock of the Company represented at the Annual Meeting, in person or proxy, was 62,144,531 shares, or approximately 91% of the outstanding voting shares of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, the Company&#8217;s shareholders were asked to vote on the election of twelve directors and the five other proposals described below, and the votes were cast as follows: </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. &#160;&#160;&#160;&#160;Election of the following directors for terms expiring in 2022 or until their respective successors are elected and qualified: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:65%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">For</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">Against</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">Abstain</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pina Albo</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,296,025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">660,652</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">98,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine R. Detrick</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,312,685</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">649,748</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92,450</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J. Cliff Eason</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,120,094</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">840,327</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94,462</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John J. Gauthier</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,908,369</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">47,372</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">99,142</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patricia Guinn</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,910,643</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">51,827</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92,413</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anna Manning</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,908,425</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">55,179</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">91,279</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hazel M. McNeilage</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">58,708,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,253,694</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92,564</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen O&#8217;Hearn</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,912,121</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94,414</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frederick J. Sievert</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">58,554,302</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,401,283</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">99,298</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shundrawn Thomas</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,906,054</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">49,060</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">99,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stanley B. Tulin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,906,115</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">54,190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94,578</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven C. Van Wyk</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,909,332</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46,290</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">99,261</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,089,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.&#160;&#160;&#160;&#160;Advisory vote to approve the compensation of the Company&#8217;s named executive officers: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Withheld</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">56,692,324</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,750,902</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">611,657</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,089,648</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. &#160;&#160;&#160;&#160;Proposal to approve the amendments to the Company&#8217;s Flexible Stock Plan: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Withheld</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">55,361,277</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">4,568,610</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">124,996</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,089,648</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. &#160;&#160;&#160;&#160;Proposal to approve the amendments to the Company&#8217;s Flexible Stock Plan for Directors: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Withheld</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">56,241,116</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">3,698,920</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">114,847</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,089,648</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. &#160;&#160;&#160;&#160;Proposal to approve the Company&#8217;s Amended&#160;&amp; Restated Phantom Stock Plan for Directors: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Withheld</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">59,347,147</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">590,806</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">116,930</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,089,648</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.&#160;&#160;&#160;&#160;Proposal to ratify the appointment of Deloitte&#160;&amp; Touche LLP as the Company&#8217;s independent auditor for the fiscal year ending December&#160;31, 2021: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Withheld</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">59,568,006</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,483,745</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">92,780</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">0</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) &#160;&#160;&#160;&#160;Exhibits. The following documents are filed as exhibits to this report: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:94%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d173454dex101.htm">Amendment to the Reinsurance Group of America, Incorporated Flexible Stock Plan, effective May&#160;19, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d173454dex102.htm">Amendment to the Reinsurance Group of America, Incorporated Flexible Stock Plan for Directors, effective May&#160;19, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d173454dex103.htm">Reinsurance Group of America, Incorporated Phantom Stock Plan for Directors, as amended and restated effective May&#160;19, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (formatted as Inline XBRL) to the exhibit index</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">REINSURANCE GROUP OF AMERICA, INCORPORATED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: May&#160;20, 2021</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Todd C. Larson</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Todd C. Larson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Senior Executive Vice President and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d173454dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS TO THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLEXIBLE STOCK PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Effective May&nbsp;19, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Reinsurance Group of America, Incorporated (the &#147;Company&#148;) established the Reinsurance Group of America, Incorporated
Flexible Stock Plan (the &#147;Plan&#148;) to enhance the ability of the Company to reward and provide stock based incentives to its employees, consultants, and independent contractors; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on March&nbsp;31, 2021, the Compensation Committee of the Board of Directors of the Company approved amendments to the Plan, subject
to shareholder approval, to increase the total number of shares authorized for issuance under the Plan by 1,500,000 for a total of 16,460,077 shares and extend the termination date of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, the Company hereby amends the Plan as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Effective upon the date of approval of this amendment by the Company&#146;s shareholders, Section&nbsp;3.1 of the Plan is amended in its
entirety to read as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3.1 <U>Number of Shares</U>. The number of Shares which may be issued or sold or for which Options, SARs,
Restricted Stock, RSUs, Performance Shares or other Stock Based Awards may be granted under the Plan shall be 16,460,077 Shares, determined as 1,500,000 Shares available on and after the Effective Date plus the 14,960,077 Shares that were available
under the terms of the Plan prior to the Effective Date to the extent such Shares remain outstanding and available or become outstanding and available again hereunder. Such Shares may be authorized but unissued Shares (subject to payment of any
required par value), Shares held in the treasury, or both. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Effective upon the date of approval of this amendment by the Company&#146;s
shareholders, Section&nbsp;7.2 of the Plan is amended in its entirety to read as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">7.2 <U>Termination</U>. The Plan will terminate
automatically on May&nbsp;19,&nbsp;2026. In addition, the Plan may be terminated at any time by the Board. The Plan will remain in effect with respect to outstanding Benefits until no Benefits remain outstanding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Capitalized terms used herein shall have the same meanings ascribed to them in the Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Reinsurance Group of America, Incorporated hereby adopts the foregoing
amendments this 19th day of May, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="55%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">REINSURANCE GROUP OF AMERICA, INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Anna Manning</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Anna Manning, President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLEXIBLE STOCK PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As
Amended and Restated Effective May&nbsp;23, 2017 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLEXIBLE STOCK PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE I </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NAME AND
PURPOSE </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.1 <U>Name</U>. The name of this Plan is the &#147;Reinsurance Group of America, Incorporated Flexible Stock Plan.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.2 <U>Purpose</U>. The Company has established this Plan to attract, retain, motivate and reward Employees and other individuals, to encourage
ownership of the Company&#146;s Common Stock by Employees and other individuals, and to promote and further the best interests of the Company by granting cash and other awards. The Plan is hereby amended and restated as provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE II </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DEFINITIONS
OF TERMS AND RULES OF CONSTRUCTION </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1 <U>General Definitions</U>. The following words and phrases, when used in the Plan, unless
otherwise specifically defined or unless the context clearly otherwise requires, shall have the following respective meanings: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Affiliate</U>. Any corporation that is a Subsidiary of the Company or a Subsidiary of a Parent and, for
purposes other than the grant of ISOs, any limited liability company, partnership, corporation, joint venture, or any other entity in which the Company or any such Subsidiary owns an equity interest. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Agreement</U>. A written contract entered into between the Company or an Affiliate and a Participant or, in
the discretion of the Committee, a written certificate issued by the Company or an Affiliate to a Participant, in either case, containing or incorporating the terms and conditions of a Benefit in such form (not inconsistent with this Plan) as the
Committee approves from time to time, together with all amendments thereof, which amendments may be made unilaterally by the Company (with the approval of the Committee) unless such amendments are deemed by the Committee to be materially adverse to
the Participant and are not required as a matter of law, or such other relevant written contract entered into between the Company or an Affiliate and a Participant and approved by the Committee. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Benefit</U>. Any benefit granted to a Participant under the Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Board</U>. The Board of Directors of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Cash Award</U>. A Benefit payable in the form of cash. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Change of Control</U>. The acquisition, without the approval of the Board, by any person or entity, other
than the Company or a Related Entity, of more than 20% of the outstanding Shares through a tender offer, exchange offer or otherwise; the liquidation or dissolution of the Company following a sale or other disposition of all or substantially all of
its assets; a merger or consolidation involving the Company which results in the Company not being the surviving parent corporation; or any time during any <FONT STYLE="white-space:nowrap">two-year</FONT> period in which individuals who constituted
the Board at the start of such period (or whose election was approved by at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the then members of the Board who were members at the start of the
<FONT STYLE="white-space:nowrap">two-year</FONT> period) do not constitute at least 50% of the Board for any reason. A &#147;Related Entity&#148; is the Parent, a Subsidiary or any employee benefit plan (including a trust forming a part of such a
plan) maintained by the Parent, the Company or a Subsidiary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Code</U>. The Internal Revenue Code of 1986, as amended and in effect from time to time, or any successor
statute. Any reference to the Code includes the regulations promulgated pursuant to the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Company</U>. Reinsurance Group of America, Incorporated, a Missouri corporation, or any successor to all or
substantially all of its business by merger, consolidation, purchase of assets or otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Committee</U>. The Committee described in Section&nbsp;5.1. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Common Stock</U>. Any class of the Company&#146;s common stock or any securities issued in respect thereof
by the Company or any successor to the Company as a result of an event described in Section&nbsp;3.3 or ARTICLE IX hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Effective Date</U>. The date that the Plan, as amended and restated herein, is approved by the shareholders
of the Company which must occur within one year before or after approval by the Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Employee</U>. Any person employed as either a regular full-time employee or part-time employee by the
Employer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Employer</U>. The Company and all Affiliates. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Exchange Act</U>. The Securities Exchange Act of 1934, as amended. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Fair Market Value</U>. The closing price of a Share on the New York Stock Exchange on a given date, or, in
the absence of sales on a given date, the closing price on the New York Stock Exchange on the last day on which a sale occurred prior to such date. If the Shares are not listed on the New York Stock Exchange, Fair Market Value shall be what the
Committee determines in good faith to be 100% of the fair market value of a Share on that date. In the case of an ISO, if such determination of Fair Market Value is not consistent with the then current regulations of the Secretary of the Treasury,
Fair Market Value shall be determined in accordance with said regulations. The determination of Fair Market Value shall be subject to adjustment as provided in Section&nbsp;3.3 and ARTICLE IX hereof. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Fiscal Year</U>. The taxable year of the Company which is the calendar year. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ISO</U>. An Incentive Stock Option as defined in Section&nbsp;422 of the Code, or any successor to such
section. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>NQSO</U>. A <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option, which is an Option that does
not qualify as an ISO. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Option</U>. An option to purchase Shares granted under the Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(t)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Parent</U>. Any corporation that is a &#147;parent corporation,&#148; as that term is defined in
Section&nbsp;424(e) of the Code, or any successor provision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(u)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Participant</U>. An individual who is granted a Benefit under the Plan. Benefits may be granted to
Employees, consultants and independent contractors of the Company or an Affiliate, in the sole discretion of the Committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Performance Share</U>. A Share awarded to a Participant under ARTICLE XVI of the Plan.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(w)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Plan</U>. The Reinsurance Group of America, Incorporated Flexible Stock Plan, as amended and restated
herein, and all further amendments and supplements to it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Restricted Stock</U>. Shares issued under ARTICLE XV of the Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(y)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>RSU</U>. A restricted stock unit, which represents the Participant&#146;s right to receive one Share for
each RSU held on the scheduled vesting date or other specified payment date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(z)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>. Rule <FONT STYLE="white-space:nowrap">16b-3</FONT>
promulgated by the SEC under the Exchange Act, as amended, or any successor rule in effect from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(aa)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>SEC</U>. The Securities and Exchange Commission. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(bb)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Share</U>. A share of Common Stock. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(cc)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>SAR</U>. A stock appreciation right, which is the right to receive an amount equal to the appreciation, if
any, in the Fair Market Value of a Share from the date of the grant of the right to the date of its payment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(dd)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Stock Based Award</U>. An award under ARTICLE XVIII that is valued in whole or in part by reference to, or
is otherwise based on, Common Stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ee)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Subsidiary</U>. Any corporation that is a &#147;subsidiary corporation,&#148; as that term is defined in
Section&nbsp;424(f) of the Code, or any successor provision. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2 <U>Other Definitions</U>. In addition to the above
definitions, certain words and phrases used in the Plan and any Agreement may be defined in other portions of the Plan or in such Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.3 <U>Conflicts in Plan</U>. In the case of any conflict in the terms of the Plan relating to a Benefit, the provisions in the ARTICLE of the
Plan which specifically provides for such Benefit shall control those in a different ARTICLE. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE III </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>COMMON STOCK </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.1
<U>Number of Shares</U>. The number of Shares which may be issued or sold or for which Options, SARs, Restricted Stock, RSUs, Performance Shares or other Stock Based Awards may be granted under the Plan shall be 14,960,077 Shares, determined as
1,600,000 Shares available on and after the Effective Date plus the 13,360,077 Shares that were available under the terms of the Plan prior to the Effective Date to the extent such Shares remain outstanding and available or become outstanding and
available again hereunder. Such Shares may be authorized but unissued Shares (subject to payment of any required par value), Shares held in the treasury, or both. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.2 <U>Reusage</U>. If an Option or SAR expires or is terminated, surrendered or cancelled without having been fully exercised, if Restricted
Stock, RSUs or Performance Shares are forfeited, or if any other grant results in any Shares not being issued, the Shares covered by such Option or SAR, grant of Restricted Stock, RSUs, Performance Shares or other grant, as the case may be, shall
again be available for use under the Plan. In addition, Shares tendered or withheld in payment of the exercise price for an Option or SAR or in satisfaction of withholding taxes for any Benefit shall be available again for use under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3 <U>Adjustments</U>. If there is any change in the Common Stock of the Company by reason of any extraordinary dividend, stock dividend, <FONT
STYLE="white-space:nowrap">spin-off,</FONT> <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-out,</FONT> recapitalization, warrant or rights issuance or combination, exchange or reclassification of shares,
merger, consolidation, reorganization, sale of substantially all assets or, in the Committee&#146;s sole discretion, other similar or relevant event, then the number, kind and class of shares available for grants of Options, SARs, Restricted Stock,
RSUs, Performance Shares and Other Stock Based Awards and the number, kind and class of shares subject to outstanding Options, SARs, grants of Restricted Stock, RSUs and Performance Shares which are not vested, and Other Stock Based Awards, and the
price thereof, as applicable, shall be appropriately adjusted by the Committee. The adjustment provisions of this Section&nbsp;3.3 shall apply to individual limitations under the Plan (e.g., limitations on the number of shares covered by any type of
Benefit in any one year period). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4 <U>Exclusions from Share Limitation</U>. The following will not be applied to the Share limitations
of Section&nbsp;3.1 above: (a)&nbsp;dividends or dividend equivalents paid in cash in connection with outstanding Benefits, (b)&nbsp;Benefits which by their terms may be settled only in cash, (c)&nbsp;any Shares subject to a Benefit under the Plan
which Benefit is forfeited, cancelled, terminated, expires or lapses for any reason, and (d)&nbsp;Shares and any Benefits that are granted through the settlement, assumption, or substitution of outstanding awards previously granted, or through
obligations to grant future awards, as the result of a merger, consolidation, or acquisition of the employing company with or by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IV </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ELIGIBILITY </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1
<U>Determined By Committee</U>. The Participants and the Benefits they receive under the Plan shall be determined solely by the Committee. In making its determinations, the Committee shall consider past, present and expected future contributions of
Participants and potential Participants to the Employer, including, without limitation, the performance of, or the refraining from the performance of, services. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE V </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ADMINISTRATION </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.1
<U>Committee</U>. The Plan shall be administered by the Compensation Committee of the Board, its successor or such other committee as the Board may designate (the &#147;Committee&#148;). The members of the Committee shall be appointed by and shall
serve at the pleasure of the Board, which may from time to time appoint members in substitution for members previously appointed and fill vacancies, however caused, in the Committee. The Committee may select one of its members as its Chairman and
shall hold its meetings at such times and places as it may determine. A majority of the Committee&#146;s members shall constitute a quorum. All determinations of the Committee shall be made by a majority of its members. Any decision or determination
reduced to writing and signed by a majority of the members shall be fully as effective as if it had been made by a majority vote at a meeting duly called and held. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2 <U>Authority</U>. Subject to the terms of the Plan, the Committee shall have discretionary authority to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the individuals to whom Benefits are granted, the type and amounts of Benefits to be granted and the
time of all such grants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the terms, conditions, provisions and restrictions that may apply to each Benefit granted, which
determinations of the terms, conditions, provisions and restrictions need not be uniform among all Participants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interpret and construe the Plan and all Agreements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prescribe, amend and rescind rules and regulations relating to the Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the content and form of all Agreements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine all questions relating to Benefits under the Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make all determinations as to the right to Benefits under the Plan, including the authority to review and
approve or deny Participant claims for benefits; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">maintain accounts, records and ledgers relating to Benefits; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">maintain records concerning its decisions and proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">employ agents, attorneys, accountants or other persons for such purposes as the Committee considers necessary
or desirable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">take, at any time, any action permitted by Section&nbsp;9.1 irrespective of whether any Change of Control has
occurred or is imminent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">do and perform all acts which it may deem necessary or appropriate for the administration of the Plan and carry
out the purposes of the Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">correct any defect, supply any omission or reconcile any inconsistency in this Plan or in any Benefit in the
manner and to the extent it shall deem desirable. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All determinations of the Committee in the administration of this Plan, as described
herein, shall be final, binding and conclusive, including, without limitation, as to any adjustments pursuant to Section&nbsp;3.3. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.3
<U>Delegation</U>. Except as required by Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> with respect to grants of Options, SARs, Restricted Stock, RSUs, Performance Shares, other Stock Based Awards, or other Benefits to individuals who are
subject to Section&nbsp;16 of the Exchange Act or as otherwise required for compliance with Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> Code Section&nbsp;162(m), or other applicable law, the Committee may delegate all or any part of its
authority under the Plan to any Employee, Employees or committee and may authorize further delegation by such committees to senior managers of the Company, in each case to the extent permitted by Missouri law; provided that, determinations regarding
the timing, pricing, amount and terms of any Benefit to a &#147;reporting person&#148; for purposes of Section&nbsp;16 of the Exchange Act shall be made only by the Committee; and provided further that, no such delegation may be made that would
cause Benefits or other transactions under this Plan to cease to be exempt from Section&nbsp;16(b) of the Exchange Act or cause a Benefit intended to qualify for favorable treatment under Section&nbsp;162(m) of the Code not to qualify for, or to
cease to qualify for, the favorable treatment under Section&nbsp;162(m) of the Code. Any such delegation may be revoked by the Committee at any time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4 <U>Board Authority</U>. Any authority granted to the Committee may also be exercised by the Board or another committee of the Board, except
to the extent that the grant or exercise of such authority would cause any Benefit intended to qualify for favorable treatment under Section&nbsp;162(m) of the Code to cease to qualify for the favorable treatment under Section&nbsp;162(m) of the
Code. To the extent that any permitted action taken by the Board conflicts with action taken by the Committee, the Board action shall control. Without limiting the generality of the foregoing, to the extent the Board has delegated any authority
under this Plan to another committee of the Board, such authority shall not be exercised by the Committee unless expressly permitted by the Board in connection with such delegation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VI </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AMENDMENT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.1 <U>Power
of Board</U>. Except as hereinafter provided, the Board shall have the sole right and power to amend the Plan at any time and from time to time. Except as provided in this ARTICLE VI, the Committee may at any time alter or amend any or all
Agreements under this Plan to the extent permitted by law and subject to the requirements of Section&nbsp;2.1(b), in which event, as provided in Section&nbsp;2.1(b), the term &#147;Agreement&#148; shall mean the Agreement as so amended. No
termination, suspension or modification of this Plan may materially and adversely affect any right acquired by any Participant (or a Participant&#146;s legal representative) or any successor or permitted transferee under a Benefit granted before the
date of termination, suspension or modification, unless otherwise provided in an Agreement or otherwise or required as a matter of law. It is conclusively presumed that any adjustment for changes in capitalization in accordance with Section&nbsp;3.3
or <U>Appendix A</U> hereof does not adversely affect any right of a Participant or other person under a Benefit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.2 <U>Limitation</U>.
The Board may not amend the Plan, without approval of the shareholders of the Company: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in a manner which would cause Options which are intended to qualify as ISOs to fail to qualify;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in a manner which would cause the Plan to fail to meet the requirements of Rule
<FONT STYLE="white-space:nowrap">16b-3</FONT> or Code Section&nbsp;162(m); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in a manner which would violate applicable law, regulation or stock exchange requirement.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TERM AND TERMINATION </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1
<U>Term</U>. The original effective date of the Plan was January&nbsp;1, 1997 and the Plan as Amended and Restated herein shall commence as of the Effective Date and, subject to the terms of the Plan, including those requiring approval by the
shareholders of the Company and those limiting the period over which ISOs or any other Benefits may be granted, shall continue in full force and effect until terminated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2 <U>Termination</U>. The Plan will terminate automatically on May&nbsp;23, 2022. In addition, the Plan may be terminated at any time by the
Board. The Plan will remain in effect with respect to outstanding Benefits until no Benefits remain outstanding. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VIII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MODIFICATION OR TERMINATION OF BENEFITS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1 <U>General</U>. Subject to the provisions of Section&nbsp;8.2, the amendment or termination of the Plan shall not adversely affect a
Participant&#146;s right to any Benefit granted prior to such amendment or termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2 <U>Committee&#146;s Right</U>. Any Benefit granted may be converted, modified, forfeited
or cancelled, in whole or in part, by the Committee if and to the extent permitted in the Plan or applicable Agreement or with the consent of the Participant to whom such Benefit was granted. The Committee may, for such consideration (if any) as it
may deem adequate and with the prior consent of the Participant, modify the terms of an outstanding Option or SAR; provided, however, that except to the extent permitted by Section&nbsp;8.3, no Option or SAR may be repriced, replaced or regranted
through cancellation, or by lowering the exercise price of such Benefit, and no such Benefit with an exercise price that exceeds Fair Market Value of a share of Common Stock shall be canceled, purchased or exchanged for a cash payment, without
shareholder approval. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3 <U>Special Modification in the Event of a Corporate Transaction</U>. In the event of a corporate transaction
(within the meaning of Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.424-1(a)(3)),</FONT> the Committee may provide for the assumption or substitution of outstanding Options or SARs, provided that the requirements of Treas. Reg. &#167; <FONT
STYLE="white-space:nowrap">1.424-</FONT> 1(a) are satisfied with respect to ISOs, and the requirements of Treas. Reg. &#167; 1.409A- 1(b)(v)(D) are satisfied with respect to all other Options. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4 <U>No Discounted Options or SARs; No Repricing</U>. Options and SARs may not be granted with an exercise price lower than the Fair Market
Value of the underlying Shares on the grant date (except to the extent awards are assumed or substituted in connection with a corporate transaction as described in Section&nbsp;8.3). The exercise price of an Option or SAR shall not be reduced after
grant, including by reason of cancellation, cash buyout or exchange of an underwater Option or SAR, without shareholder approval. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IX </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CHANGE OF
CONTROL </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <U>Right of Committee</U>. In order to maintain a Participant&#146;s rights in the event of a Change in Control, the
Committee, in its sole discretion, may, in any Agreement evidencing a Benefit, or at any time prior to, or simultaneously with or after a Change in Control, provide such protection as it may deem necessary. Without, in any way, limiting the
generality of the foregoing provisions or requiring any specific protection, the Committee may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">provide for the acceleration of any time periods relating to the exercise or realization of such Benefit so
that such Benefit may be exercised or realized in full on or before a date fixed by the Committee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">provide for the purchase of such Benefit, upon the Participant&#146;s request, for an amount of cash equal to
the amount which could have been attained upon the exercise or realization of such Benefit had such Benefit been currently exercisable or payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make such adjustment to the Benefits then outstanding as the Committee deems appropriate to reflect such
transaction or change; and/or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">cause the Benefits then outstanding to be assumed, or new Benefits substituted therefor, by the surviving
corporation in such change. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE X </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AGREEMENTS AND CERTAIN BENEFITS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.1 <U>Grant Evidenced by Agreement</U>. The grant of any Benefit under the Plan may be evidenced by an Agreement which shall describe the
specific Benefit granted and the terms and conditions of the Benefit. The granting of any Benefit may be subject to, and conditioned upon, the recipient&#146;s execution of any Agreement to the extent required by the Committee. All capitalized terms
used in an Agreement shall have the same meaning as in the Plan, except as otherwise provided in the Agreement. An Agreement shall be subject to all of the terms of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2 <U>Provisions of Agreement</U>. Each Agreement shall contain such provisions that the Committee shall determine to be necessary, desirable
and appropriate for the Benefit granted which may include, but not be limited to, the following with respect to any Benefit: description of the type of Benefit; the Benefit&#146;s duration; its transferability; if an Option, the exercise price, the
exercise period and the person or persons who may exercise the Option; the effect upon such Benefit of the Participant&#146;s death or termination of employment; the Benefit&#146;s conditions; when, if, and how any Benefit may be forfeited,
converted into another Benefit, modified, exchanged for another Benefit, or replaced; and the restrictions on any Shares purchased or granted under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.3 <U>Certain Benefits</U>. Except as otherwise expressly provided in an Agreement, any Benefit granted to an individual who is subject to
Section&nbsp;16 of the Exchange Act shall not be transferable other than by will or the laws of descent and distribution and shall be exercisable during his lifetime only by him, his guardian or his legal representative. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.4 <U>Minimum Vesting</U>. Notwithstanding anything herein to the contrary, except with respect to an aggregate of up to 5% of the Shares
available pursuant to Article III of the Plan for Benefits granted on or following May&nbsp;23, 2017, no Benefit will become exercisable or otherwise nonforfeitable unless such Benefit has been outstanding for a minimum period of one year from its
date of grant; provided, that all awards of Restricted Stock or Shares shall become nonforfeitable after a minimum period of one year from their dates of grant. Notwithstanding the foregoing, the vesting of a Benefit may be accelerated in the
Committee&#146;s sole discretion in the case of the Participant&#146;s death, disability or retirement or upon a Change of Control. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XI </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TANDEM
AWARDS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1 <U>Tandem Awards</U>. Awards may be granted by the Committee in tandem. However, no Benefit may be granted in tandem with
an ISO except SARs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>PAYMENT, DIVIDENDS, DEFERRAL AND WITHHOLDING </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.1 <U>Payment</U>. Upon the exercise of an Option or in the case of any other Benefit that requires a payment to the Company, the amount due
the Company is to be paid: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in cash; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by the tender to the Company of Shares owned by the Participant and registered in his name having a Fair Market
Value equal to the amount due to the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in other property, rights and credits, including the Participant&#146;s promissory note if permitted under
applicable law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by net exercise; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by any combination of the payment methods specified in (a), (b), (c) and (d)&nbsp;above. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, any method of payment other than cash may be used only with the consent of the Committee or if and to the extent so provided in
an Agreement. The proceeds of the sale of Common Stock purchased pursuant to an Option and any payment to the Company for other Benefits shall be added to the general funds of the Company or to the Shares held in treasury, as the case may be, and
used for the corporate purposes of the Company as the Board shall determine. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2 <U>Dividend Equivalents</U>. Grants of Benefits in
Shares or Share equivalents may include dividend equivalent payments or dividend credit rights. The payment of dividend equivalents or dividend credits attributable to an unvested Benefit is not permitted during the period in which the Benefit is
unvested. Dividend equivalents and dividend credits may be accumulated during the vesting period of the underlying Benefit and paid out only to the extent the Benefit has vested. Additionally, Participants holding Options or SARs shall not be
granted dividend equivalents or dividend credits for any period prior to the exercise of such Option or SAR. While RSUs or other Benefits may be granted with dividend equivalent rights, any dividend equivalents with respect to RSUs or other Benefits
that are earned based on the achievement of performance goals will be accumulated until the underlying stock units are earned, and such dividend equivalents will not be paid if the performance goals are not satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3 <U>Deferral</U>. The right to receive any Benefit under the Plan may, at the request of the Participant, be deferred for such period and
upon such terms as the Committee shall determine, which may include crediting of interest on deferrals of cash and crediting of dividends on deferrals denominated in Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.4 <U>Withholding</U>. The Company, at the time any distribution is made under the Plan, whether in cash or in Shares, may withhold from such
distribution any amount necessary to satisfy federal, state and local income tax withholding requirements with respect to such distribution. Such withholding may be in cash or in Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XIII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OPTIONS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.1 <U>Types of
Options</U>. It is intended that both ISOs and NQSOs may be granted by the Committee under the Plan, with terms not in excess of ten years. In no event may Options known as &#147;reload options&#148; or other automatic grants to Participants be
granted under the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2 <U>Shares for ISOs</U>. The number of Shares for which ISOs may be granted on or after the Effective Date
shall not exceed 150,000 Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.3 <U>Grant of ISOs and Option Price</U>. Each ISO must be granted to an Employee and granted within
ten years from the Effective Date. The purchase price for Shares under any ISO shall be no less than the Fair Market Value of the Shares at the time the Option is granted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.4 <U>Other Requirements for ISOs</U>. The terms of each Option which is intended to qualify as an ISO shall meet all requirements of
Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.5 <U>NQSOs</U>. The terms of each NQSO shall provide that such Option will not be treated as an ISO. The
purchase price for Shares under any NQSO shall be equal to or greater than the Fair Market Value of the Shares at the time the Option is granted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.6 <U>Determination by Committee</U>. Except as otherwise provided in Section&nbsp;13.2 through Section&nbsp;13.5, the terms of all Options
shall be determined by the Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.7 <U>Limitation on Shares Covered by Options</U>. The maximum number of Shares with respect to
which Options may be granted to any Participant in any one year period shall not exceed 200,000 shares. For purposes of the preceding sentence, the Shares covered by an Option that is cancelled shall count against the maximum number of Shares. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XIV </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SARS
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.1 <U>Grant and Payment</U>. The Committee may grant SARs. Upon electing to receive payment of a SAR, a Participant shall receive
payment in cash, in Common Stock or in any combination of cash and Common Stock, as the Committee shall determine. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.2 <U>Grant of Tandem
Award</U>. The Committee may grant SARs in tandem with an Option, in which case: the exercise of the Option shall cause a correlative reduction in SARs standing to a Participant&#146;s credit which were granted in tandem with the Option; and the
payment of SARs shall cause a correlative reduction of the Shares under such Option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.3 <U>ISO Tandem Award</U>. When SARs are granted
in tandem with an ISO, the SARs shall have such terms and conditions as shall be required for the ISO to qualify as an ISO. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.4
<U>Payment of Award</U>. SARs shall be paid, to the extent payment is elected by the Participant (and is otherwise due and payable), as soon as practicable after the date on which such election is made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.5 <U>Limitation on SARs</U>. The maximum number of SARs which may be granted to any Participant in any one year period shall not exceed
200,000 SARs. For purposes of the preceding sentence, any SARs that are cancelled shall count against the maximum number of SARs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XV </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RESTRICTED STOCK </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.1
<U>Description</U>. The Committee may grant Benefits in Shares available under ARTICLE III of the Plan as Restricted Stock. Shares of Restricted Stock shall be issued and delivered at the time of the grant but shall be subject to forfeiture until
provided otherwise in the applicable Agreement or the Plan. Each certificate representing Shares of Restricted Stock shall bear a legend referring to the Plan and the risk of forfeiture of the Shares and stating that such Shares are nontransferable
until all restrictions have been satisfied and the legend has been removed. The recipient shall be entitled to full voting and dividend rights with respect to all shares of Restricted Stock from the date of grant; provided, however, that dividend
payment amounts may be accumulated during the vesting period and paid out only to the extent the Restricted Stock has vested. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.2 <U><FONT
STYLE="white-space:nowrap">Non-Transferability</FONT></U>. Shares of Restricted Stock shall not be transferable until after the removal of the legend with respect to such Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.3 <U>Limitation on Restricted Stock</U>. The maximum number of Shares with respect to which Restricted Stock may be granted to any
Participant in any one year period shall not exceed 200,000 Shares. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XVI </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RSUs </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16.1
<U>Description</U>. An RSU represents the right to receive one Share of Common Stock on the scheduled vesting date or other specified payment date as provided for in the applicable award Agreement. A Participant receiving RSUs will have no rights of
a shareholder as to such RSU until such time as Shares are issued to the Participant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16.2 <U>Grant</U>. The Committee may grant an award
of RSUs. The maximum number of Shares with respect to which RSUs may be granted to any Participant in any one year period shall not exceed 200,000 Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XVII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>PERFORMANCE SHARES </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.1
<U>Description</U>. Performance Shares are the right of an individual to whom a grant of such Shares is made to receive Shares or cash equal to the Fair Market Value of such Shares at a future date in accordance with the terms of such grant.
Generally, such right shall be based upon the attainment of targeted profit and/or performance objectives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.2 <U>Grant</U>. The
Committee may grant an award of Performance Shares. The number of Performance Shares and the terms and conditions of the grant shall be set forth in the applicable Agreement. The maximum number of Shares with respect to which Performance Shares may
be granted to any Participant in any one year period shall not exceed 200,000 Shares. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XVIII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CASH AWARDS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.1
<U>Grant</U>. The Committee may grant Cash Awards at such times and (subject to Section&nbsp;18.2) in such amounts as it deems appropriate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.2 <U>Limitation on Amount</U>. The maximum amount of all Cash Awards that may be granted to any Participant in any one year period shall not
exceed $2,000,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.3 <U>Restrictions</U>. Cash Awards may be subject or not subject to conditions (such as an investment requirement),
restricted or nonrestricted, vested or subject to forfeiture and may be payable currently or in the future or both. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XIX
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STOCK BASED AWARDS AND OTHER BENEFITS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19.1 <U>Stock Based Awards</U>. The Committee shall have the right to grant other Stock Based Awards which may include, without limitation,
the grant of Shares based on certain conditions, the payment of cash based on the performance of the Common Stock, and the grant of securities convertible into Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19.2 <U>Limitation on Other Stock Based Awards</U>. The maximum number of Shares with respect to which any Other Stock Based Award may be
granted to any Participant in any one year period is 200,000 Shares in the aggregate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19.3 <U>Other Benefits</U>. The Committee shall have
the right to provide types of Benefits under the Plan in addition to those specifically listed, if the Committee believes that such Benefits would further the purposes for which the Plan was established. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XX </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MISCELLANEOUS PROVISIONS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20.1 <U>Underscored References</U>. The underscored references contained in the Plan are included only for convenience, and they shall not be
construed as a part of the Plan or in any respect affecting or modifying its provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.2 <U>Number and Gender</U>. The masculine and neuter, wherever used in the Plan, shall
refer to either the masculine, neuter or feminine; and, unless the context otherwise requires, the singular shall include the plural and the plural the singular. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.3 <U>Governing Law/Venue</U>. This Plan shall be construed and administered in accordance with the laws of the State of Missouri, without
giving regard to the conflict of laws provisions thereof. Any legal action against the Plan, the Company, an Affiliate, the Board, or the Committee may only be brought in the Circuit Court in St. Louis County and/or the United States District Court
in St. Louis, Missouri. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.4 <U>Purchase for Investment</U>. The Committee may require each person purchasing Shares pursuant to an
Option or other award under the Plan to represent to and agree with the Company in writing that such person is acquiring the Shares for investment and without a view to distribution or resale. The certificates for such Shares may include any legend
which the Committee deems appropriate to reflect any restrictions on transfer. All certificates for Shares delivered under the Plan shall be subject to such stock-transfer orders and other restrictions as the Committee may deem advisable under all
applicable laws, rules and regulations, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate references to such restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.5 <U>No Employment Contract</U>. The adoption of the Plan shall not confer upon any Employee any right to continued employment nor shall it
interfere in any way with the right of the Employer to terminate the employment of any of its Employees at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.6 <U>No Effect on
Other Benefits</U>. Payments and other benefits received by a Participant under a Benefit shall not be deemed a part of a Participant&#146;s regular, recurring compensation for purposes of any termination, indemnity or severance pay laws and shall
not be included in, nor have any effect on, the determination of benefits under any other employee benefit plan, contract or similar arrangement provided by the Company or an Affiliate, unless expressly so provided by such other plan, contract or
arrangement or the Committee determines that a Benefit or portion of a Benefit should be included to reflect competitive compensation practices or to recognize that a Benefit has been made in lieu of a portion of competitive cash compensation. The
receipt by a Participant of one type of grant shall not entitle the Participant to receipt of any other type of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.7
<U>Performance Benefits</U>. The Committee, in its discretion, may condition any of the Benefits upon achievement of one or more performance goals, as further described in Appendix A hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.8 <U>Clawback</U>. If a Participant is or subsequently becomes subject to the Company&#146;s Executive Incentive Recoupment Policy, or a
similar clawback policy that may be adopted in the future including, without limitation, any changes required to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#147;Policy&#148;), all or a portion of each Benefit
granted to such Participant will be subject to potential recoupment upon the occurrence of certain recoupment events and the Committee shall have discretion regarding application of the Policy to Benefits granted under this Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.9 <U>Rights as Shareholders</U>. A Participant shall have no right as a shareholder with respect to any Shares covered by a Benefit until
the date the Participant becomes the holder of record of such Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.10 <U>Date of Grant</U>. The date and time of approval by the Committee of the granting
of a Benefit shall be considered the date and time at which such Benefit is made or granted, or such later effective date as determined by the Committee, notwithstanding the date of any Agreement with respect to such Benefit; provided, however, that
the Committee may grant Benefits other than ISOs to Employees or to persons who are about to become Employees, to be effective and deemed to be granted on the occurrence of certain specified contingencies, provided that if the Benefit is granted to
a <FONT STYLE="white-space:nowrap">non-Employee</FONT> who is about to become an Employee, such specified contingencies shall include, without limitation, that such person becomes an Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.11 <U>Beneficiary Upon Participant&#146;s Death</U>. To the extent that the transfer of a Participant&#146;s Benefit at death is permitted
by this Plan or under an Agreement, (a)&nbsp;a Participant&#146;s Benefit shall be transferable to the beneficiary, if any, designated on forms prescribed by and filed with the Committee and (b)&nbsp;upon the death of the Participant, such
beneficiary shall succeed to the rights of the Participant to the extent permitted by law and this Plan. If no such designation of a beneficiary has been made, the Participant&#146;s legal representative shall succeed to the Benefits, which shall be
transferable by will or pursuant to laws of descent and distribution to the extent permitted by this Plan or under an Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.12
<U>Unfunded Plan</U>. This Plan shall be unfunded and the Company shall not be required to segregate any assets that may at any time be represented by Benefits under this Plan. Neither the Company, its Affiliates, the Committee, nor the Board shall
be deemed to be a trustee of any amounts to be paid under this Plan nor shall anything contained in this Plan or any action taken pursuant to its provisions create or be construed to create a fiduciary relationship between the Company and/or its
Affiliates and a Participant or successor. To the extent any person acquires a right to receive a Benefit under this Plan, such right shall be no greater than the right of an unsecured general creditor of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.13 <U>Severability</U>. In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or
invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.14 <U>Deferrals and Settlements</U>. The Committee may require or permit Participants to elect to defer the issuance of Shares or the
settlement of Benefits in cash under such rules and procedures as it may establish under this Plan. It may also provide that deferred settlements include the payment or crediting of interest on the deferral amounts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.15 <U>Limits of Liability</U>. Under the Plan: (a)&nbsp;any liability of the Company to any Participant with respect to a Benefit shall be
based solely upon contractual obligations created by this Plan and the Agreement; (b)&nbsp;except as may be required by law, neither the Company nor any member or former member of the Board or the Committee, nor any other person participating
(including participation pursuant to a delegation of authority under Section&nbsp;5.3 hereof) in any determination of any question under this Plan, or in the interpretation, administration or application of this Plan, shall have any liability to any
party for any action taken, or not taken, in good faith under this Plan; and (c)&nbsp;to the full extent permitted by law, each member and former member of the Committee and each person to whom the Committee delegates or has delegated authority
under this Plan shall be entitled to indemnification by the Company against any loss, liability, judgment, damage, cost and reasonable expense incurred by such member, former member or other person by reason of any action taken, failure to act or
determination made in good faith under or with respect to this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.16 <U>Employees Employed in Foreign Jurisdictions; <FONT
STYLE="white-space:nowrap">Sub-Plans</FONT></U>. In order to enable participants who are foreign nationals or employed outside the United States, or both, to receive Benefits under the Plan, the Committee may adopt such amendments, administrative
policies, <FONT STYLE="white-space:nowrap">sub-plans</FONT> and the like as are necessary or advisable, in the opinion of the Committee, to effectuate the purposes of the Plan and achieve favorable tax treatment or facilitate compliance
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the laws of the applicable foreign jurisdiction without otherwise violating the terms of the Plan. Therefore, to the extent the Committee determines that the restrictions imposed by this
Plan preclude the achievement of material purposes of the Benefits in jurisdictions outside of the United States, the Committee has the authority and discretion to modify those restrictions as the Committee determines to be necessary or appropriate
to conform to applicable requirements or practices of jurisdictions outside of the United States. The Committee may from time to time establish <FONT STYLE="white-space:nowrap">sub-plans</FONT> under the Plan for purposes of satisfying blue sky,
securities, tax or other laws of various jurisdictions in which the Company intends to grant Awards. Any <FONT STYLE="white-space:nowrap">sub-plans</FONT> shall contain such limitations and other terms and conditions as the Committee determines are
necessary or desirable. All <FONT STYLE="white-space:nowrap">sub-plans</FONT> shall be deemed a part of the Plan, but each <FONT STYLE="white-space:nowrap">sub-plan</FONT> shall apply only to the Participants in the jurisdiction for which the <FONT
STYLE="white-space:nowrap">sub-plan</FONT> was designed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Appendix A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All Performance Shares granted pursuant to Article XVI of this Plan, and any other compensation granted pursuant to this Plan that is intended
to constitute performance based compensation within the meaning of Section&nbsp;162(m)(4)(C) of the Code, shall be subject to attainment of one or more of the performance objectives as described in this Appendix A. This Appendix A sets forth all
applicable performance objectives upon which a grant of Performance Shares under Sections 16.1 and 16.2 of the Plan or any other Benefit may be conditioned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The performance objectives for a particular Benefit shall be established in writing in the applicable Agreement. The performance objectives
may be expressed in terms of overall Company performance or the performance of a Subsidiary, division, business unit, or an individual. The performance objectives may be stated in terms of absolute levels or relative to another company or companies
or to an index or indices or industry benchmarks, or relative to levels attained in prior years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The performance objectives shall be
based upon any one or more of the performance criteria set forth below and shall not be based on any other formal or informal performance criteria: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operating earnings or income; operating earnings or income per share; net income; total or net revenues;
operating revenue, gross or net premiums; shareholder return and/or value; retained earnings; book value or book value per share; gross or net margin; profit returns and margins; operating or net cash flow; financial return ratios; return on equity
or operating return on equity; return on average adjusted equity; relative return on equity; cumulative operating revenue growth rate; return on assets; return on invested capital; earnings per share growth; change in embedded value; embedded value
of new business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">budget achievement; expenses; expense control; market capitalization; stock price; market share; working capital;
cash available to Company from a subsidiary or subsidiaries; dividends; ratings; business trends; economic value added; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product development; client development; leadership; project progress; project completion; quality; customer
satisfaction; diversity and corporate governance. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Benefits that the Committee determines, in its sole discretion,
to grant subject to performance objectives under this Appendix A shall be granted in accordance with the following procedures: No later than the 90th day of each performance year, the Committee will establish an objective performance goal for that
performance year and while the outcome of whether or not those goals will be achieved is substantially uncertain. However, in no event will such goals be established after 25% of the period of service to which the goals relate has elapsed. The
Committee must certify the attainment of the applicable performance goal, to the extent achieved, before an award is made. The Committee may decrease the actual award amount paid to a Participant for any performance year based on such secondary
goals and considerations as may be determined by the Committee in its sole discretion. The Committee will not change the material terms of the performance goals or the maximum amount payable with respect to any award to an individual covered by
Section&nbsp;162(m) of the Code, without first obtaining shareholder approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Committee may determine, prior to the date the
performance criteria are established in writing, to provide for adjustment of the performance criteria to the extent permitted under Code Section&nbsp;162(m), to account for the effects of: (i)&nbsp;acquisitions; divestitures; extraordinary
dividends; stock <FONT STYLE="white-space:nowrap">split-ups;</FONT> stock dividends or distributions; recapitalizations; warrants or rights issuances or combinations; exchanges or reclassifications with respect to any outstanding class or series of
the Company&#146;s common stock; (ii)&nbsp;a corporate transaction, such as any merger of the Company with another corporation; any consolidation of the Company and another corporation into another corporation; any separation of the Company or its
business units (including a <FONT STYLE="white-space:nowrap">spin-off,</FONT> <FONT STYLE="white-space:nowrap">split-off</FONT> or other distribution of stock or property by the Company); any reorganization of the Company (whether or not such
reorganization comes within the definition of such term in </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Code Section&nbsp;368); (iii) any partial or complete liquidation by the Company; sale of all or substantially all of the assets of the Company; (iv)&nbsp;the impact of changes in tax rates or
currency fluctuations; unusual or <FONT STYLE="white-space:nowrap">non-recurring</FONT> accounting impacts or changes in accounting standards or treatment; (v)&nbsp;expenditures outside of annual business plans; events such as sales or closing of
facilities or operations; business restructurings;&nbsp;and (vi)&nbsp;unusual or extraordinary items. The performance criteria may be applicable to the Company and/or any of its subsidiaries or individual business units and may differ from
participant to participant. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d173454dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT TO THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLEXIBLE STOCK PLAN FOR DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Effective May&nbsp;19, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Reinsurance Group of America, Incorporated (the &#147;Company&#148;) established the Reinsurance Group of America, Incorporated
Flexible Stock Plan for Directors (the &#147;Plan&#148;) to enhance the ability of the Company to reward and provide stock based incentives to its <FONT STYLE="white-space:nowrap">non-employee</FONT> directors; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on March&nbsp;31, 2021, the Compensation Committee of the Board of Directors of the Company approved an amendment to the Plan,
subject to shareholder approval, to increase the total number of shares authorized for issuance under the Plan by 25,000 shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, the Company hereby amends the Plan as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Effective upon the date of approval of this amendment by the Company&#146;s
shareholders, Section&nbsp;3.1 of the Plan is amended in its entirety to read as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3.1 <U>Number of Shares</U>. The number of
Shares which may be issued or sold or for which other Stock Based Awards may be granted under the Plan shall be 307,500 Shares. Such Shares may be authorized but unissued Shares (subject to payment of any required par value), Shares held in the
treasury, or both. The maximum dollar amount with respect to which Benefits may be granted to any Participant under the Plan in any one year period shall not exceed $900,000. Pursuant to Section&nbsp;9.3 of the Plan, any Shares subject to a
Participant&#146;s election pursuant to Section&nbsp;9.3 of this Plan generally shall not be counted against the Share reserve of this Plan and shall, instead, count against Shares granted pursuant to the Phantom Stock Plan for Directors of
Reinsurance Group of America, Incorporated as amended from time to time (&#147;Phantom Plan&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Capitalized terms used herein
shall have the same meanings ascribed to them in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Reinsurance Group of America, Incorporated hereby adopts
the foregoing amendment this 19th day of May, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">REINSURANCE GROUP OF AMERICA, INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Anna Manning</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Anna Manning, President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLEXIBLE STOCK PLAN FOR DIRECTORS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As Amended and Restated Effective May&nbsp;23, 2017 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLEXIBLE STOCK PLAN FOR DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE </U>I </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NAME AND
PURPOSE </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Name</U>. The name of this plan shall be the Flexible Stock Plan for Directors of Reinsurance Group of America,
Incorporated (the &#147;Plan&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Purpose</U>. The purpose of the Plan is to encourage the highest level of director
performance by members of the Board of Directors of Reinsurance Group of America, Incorporated by providing certain outside directors with compensation based in part on the value of the Company&#146;s Common Stock. The Plan is hereby amended and
restated as provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE II </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DEFINITIONS OF TERMS AND RULES OF CONSTRUCTION </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>General Definitions</U>. The following words and phrases, when used in the Plan, unless otherwise specifically defined or unless the
context clearly otherwise requires, shall have the following respective meanings: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Affiliate</U>. A Parent or Subsidiary of the Company, a Subsidiary of a Parent and any limited liability
company, partnership, corporation, joint venture, or any other entity in which the Company or any such Subsidiary owns an equity interest. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Agreement</U>. A written contract entered into between the Company or an Affiliate and a Participant or, in
the discretion of the Board, a written certificate issued by the Company or an Affiliate to a Participant, in either case, containing or incorporating the terms and conditions of a Benefit in such form (not inconsistent with this Plan) as the Board
approves from time to time, together with all amendments thereof, which amendments may be made unilaterally by the Company (with the approval of the Board) unless such amendments are deemed by the Board to be materially adverse to the Participant
and are not required as a matter of law, or such other relevant written contract entered into between the Company or an Affiliate and a Participant and approved by the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Benefit</U>. Any benefit granted to a Participant under the Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Board</U>. The Board of Directors of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Change of Control</U>. The acquisition, without the approval of the Board, by any person or entity, other
than the Company or a Related Entity, of more than 20% of the outstanding Shares through a tender offer, exchange offer or otherwise; the liquidation or dissolution of the Company following a sale or other disposition of all or substantially all of
its assets; a merger or consolidation involving the Company which results in the Company not being the surviving parent corporation; or any time during any two-year period in which individuals who constituted the Board at the start of such period
(or whose election was approved by at least two-thirds of the then members of the Board who were members at the start of the two-year period) do not constitute at least 50% of the Board for any reason. A &#147;Related Entity&#148; is the Parent, a
Subsidiary or any employee benefit plan (including a trust forming a part of such a plan) maintained by the Parent, the Company or a Subsidiary. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Code</U>. The Internal Revenue Code of 1986, as amended and in effect from time to time, or any successor
statute. Any reference to the Code includes the regulations promulgated pursuant to the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Company</U>. Reinsurance Group of America, Incorporated, a Missouri corporation, or any successor to all or
substantially all of its business by merger, consolidation, purchase of assets or otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Common Stock</U>. The Company&#146;s common stock, par value $.01 per share, or any securities issued in
respect thereof by the Company or any successor to the Company as a result of an event described in Section&nbsp;3.3 or ARTICLE VII hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Date of Grant</U>. The date on which a Benefit is granted under the Plan, which shall be no later than the
date on which the Board approves such Benefit. If the Board approves the award of any Benefit that is to be granted on a future date or upon the occurrence of a future event (such as a Board meeting), the Date of Grant of such Benefit shall be such
future date or the date on which such event occurs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Disability</U>. A physical or mental condition arising on or after the effective date of the Plan which, in
the opinion of a qualified doctor of medicine chosen by the Company, permanently prevents a Participant from carrying out his or her duties as a member of the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Effective Date</U>. The date that the Plan, as amended and restated herein, is approved by the shareholders
of the Company, which must occur within one year before or after approval by the Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Exchange Act</U>. The Securities Exchange Act of 1934, as amended. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Fair Market Value</U>. The closing price of a Share on the New York Stock Exchange on a given date, or, in
the absence of sales on such date, the closing price on the New York Stock Exchange on the last day on which a sale occurred prior to such date. If the Shares are not listed on the New York Stock Exchange, Fair Market Value shall be what the Board
determines in good faith to be 100% of the fair market value of a Share on that date. The determination of Fair Market Value shall be subject to adjustment as provided in Section&nbsp;3.3 and ARTICLE VII hereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Malfeasance</U>. (1)&nbsp;Conduct, act or omissions which are contrary to a Participant&#146;s duties as a
member of the Board or contrary to the best interests of the Company or any of its Affiliates, or which permit removal of a Participant from the Board for cause as provided in the Company&#146;s bylaws or (2)&nbsp;employment of a Participant by or
association of a Participant with an organization which competes with the business of the Company or any of its Affiliates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</U>. A member of the Board who is not an
officer or employee of the Company or any of its Affiliates. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Option</U>. An option to purchase Shares granted under the Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Parent</U>. Any corporation that is a &#147;parent corporation,&#148; as that term is defined in
Section&nbsp;424(e) of the Code, or any successor provision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Participant</U>. An individual who is granted a Benefit under the Plan. Benefits may be granted only to
persons who are Non-Employee Directors at the time of grant in the sole discretion of the Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Performance Unit</U>. A hypothetical Share of Common Stock allocated to a Participant on the Company&#146;s
records based on the Fair Market Value of the Common Stock as of the Date of Grant. One Performance Unit entitles the individual to whom it is granted to receive one Share or cash equal to the Fair Market Value of one Share at a future date in
accordance with the terms of such grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(t)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Plan Year</U>. The taxable year of the Company, which is currently the calendar year. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(u)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Restricted Stock</U>. Shares of Common Stock that are subject to forfeiture until provided otherwise in the
applicable Agreement or the Plan or as legended on the certificate representing such Shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Retirement</U>. Retirement of a Participant as a member of the Board, other than for failure to be
renominated or reelected due to Malfeasance. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(w)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>. Rule <FONT STYLE="white-space:nowrap">16b-3</FONT>
promulgated by the SEC under the Exchange Act, as amended, or any successor rule in effect from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>SEC</U>. The Securities and Exchange Commission. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(y)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Share</U>. A share of Common Stock. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(z)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Stock Based Award</U>. An award of Common Stock (including Restricted Stock), Options, Performance Units, or
other Benefit granted under ARTICLE XlIl that is valued in whole or in part by reference to, or is otherwise based on, Common Stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(aa)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Subsidiary</U>. Any corporation that is a &#147;subsidiary corporation,&#148; as that term is defined in
Section&nbsp;424(f) of the Code, or any successor provision. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Other Definitions</U>. In addition to the above
definitions, certain words and phrases used in the Plan and any Agreement may be defined in other portions of the Plan or in such Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Conflicts in Plan</U>. In the case of any conflict in the terms of the Plan relating to a Benefit, the provisions in the ARTICLE of the
Plan which specifically provides for such Benefit shall control those in a different ARTICLE. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE lIl </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>COMMON STOCK </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Number of Shares</U>. The number of Shares which may be issued or sold or for which other Stock Based Awards may be granted under the Plan shall be 282,500 Shares. Such Shares may be authorized but unissued Shares (subject to payment of any
required par value), Shares held in the treasury, or both. The maximum dollar amount with respect to which Benefits may be granted to any Participant under the Plan in any one year period shall not exceed $900,000. Pursuant to Section&nbsp;9.3 of
the Plan, any Shares subject to a Participant&#146;s election pursuant to Section&nbsp;9.3 of this Plan generally shall not be counted against the Share reserve of this Plan and shall, instead, count against Shares granted pursuant to the Phantom
Stock Plan for Directors of Reinsurance Group of America, Incorporated as amended from time to time (&#147;Phantom Plan&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2
<U>Reusage</U>. If an Option expires or is terminated, surrendered or canceled without having been fully exercised, if Restricted Stock or Performance Units are forfeited, or if any other grant results in any Shares not being issued, the Shares
covered by such Option, grant of Restricted Stock, Performance Units or other grant, as the case may be, shall again be available for use under the Plan. In addition, Shares tendered or withheld in payment of the exercise price for Options or in
satisfaction of withholding taxes for any Benefit shall be available again for use under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Adjustments</U>. If there is
any change in the Common Stock of the Company by reason of any extraordinary dividend, stock dividend, <FONT STYLE="white-space:nowrap">spin-off,</FONT> <FONT STYLE="white-space:nowrap">split-up,</FONT>
<FONT STYLE="white-space:nowrap">spin-out,</FONT> recapitalization, warrant or rights issuance or combination, exchange or reclassification of shares, merger, consolidation, reorganization, sale of substantially all assets or in the Board&#146;s
sole discretion, other similar or relevant event, then the number, kind and class of shares available for Stock Based Awards and the number, kind and class of shares subject to outstanding Stock Based Awards, and the price thereof, as applicable,
shall be appropriately adjusted by the Board. The adjustment provisions of this Section&nbsp;3.3 shall apply to individual limitations under the Plan (e.g., limitations on the number of shares covered by any type of Benefit in any one year period).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Exclusions from Share Limitation</U>. The following will not be applied to the Share limitations of Section&nbsp;3.1 above:
(i)&nbsp;dividends or dividend equivalents paid in cash in connection with outstanding Benefits; (ii)&nbsp;Benefits which by their terms may be settled only in cash; (iii)&nbsp;any Shares subject to a Benefit under the Plan which Benefit is
forfeited, cancelled, terminated, expires or lapses for any reason; and (iv)&nbsp;Shares and any Benefits that are granted through the settlement, assumption, or substitution of outstanding awards previously granted, or through obligations to grant
future awards, as the result of a merger, consolidation, or acquisition of the employing company with or by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IV
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ADMINISTRATION </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Board</U>. The Plan shall be administered by the Board. All determinations of the Board, in its sole discretion, shall be conclusive.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Authority</U>. Subject to the terms of the Plan, and in particular Section&nbsp;4.3, the Board shall have the sole discretionary
authority to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the individuals to whom Benefits are granted, the type and amounts of Benefits to be granted and the
time of all such grants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the terms, conditions, provisions and restrictions that may apply to each Benefit granted, which
determinations of the terms, conditions, provisions and restrictions need not be uniform among all Participants; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interpret and construe the Plan and all Agreements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prescribe, amend and rescind rules and regulations relating to the Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the content and form of all Agreements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine all questions relating to Benefits under the Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make all determinations as to the right to Benefits under the Plan, including the authority to review and
approve or deny Participant claims for benefits; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">maintain accounts, records and ledgers relating to Benefits; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">maintain records concerning its decisions and proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">employ agents, attorneys, accountants or other persons for such purposes as the Board considers necessary or
desirable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">take, at any time, any action permitted by Section&nbsp;7.1 irrespective of whether any Change of Control has
occurred or is imminent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">do and perform all acts which it may deem necessary or appropriate for the administration of the Plan and to
carry out the purposes of the Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">correct any defect, supply any omission or reconcile any inconsistency in this Plan or in any Benefit in the
manner and to the extent it shall deem desirable. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All determinations of the Board in the administration of this Plan,
as described herein, shall be final, binding and conclusive, including, without limitation, as to any adjustments pursuant to Section&nbsp;3.3. In exercising such authority, the Board may obtain such advice or assistance as it deems appropriate from
persons not serving on the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE V </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AMENDMENT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Power
of Board</U>. Except as hereinafter provided and subject to Section&nbsp;5.2, the Board shall have the sole right and power to amend the Plan at any time and from time to time. Except as provided in this ARTICLE V, the Board may at any time alter or
amend any or all Agreements under this Plan to the extent permitted by law and subject to the requirements of Section&nbsp;2.1(b), in which event, as provided in Section&nbsp;2.1(b), the term &#147;Agreement&#148; shall mean the Agreement as so
amended. No termination, suspension or modification of this Plan may materially and adversely affect any right acquired by any Participant (or a Participant&#146;s legal representative) or any successor or permitted transferee under a Benefit
granted before the date of termination, suspension or modification, unless otherwise provided in an Agreement or otherwise or required as a matter of law. It is conclusively presumed that any adjustment for changes in capitalization provided for in
Sections 3.3 hereof does not adversely affect any right of a Participant or other person under a Benefit. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Limitation</U>. The Board may not amend the Plan (i)&nbsp;without approval of the
shareholders of the Company if shareholder approval would be required for such an amendment under the rules of the New York Stock Exchange or (ii)&nbsp;in a manner that would violate applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE Vl </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TERM.
TERMINATION. MODIFICATION AND REPLACEMENT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>Term</U>. The original effective date of the Plan was January&nbsp;1, 1997 and the
Plan as Amended and Restated herein shall commence on the Effective Date, subject to the terms of the Plan, including those requiring approval by the shareholders of the Company and those limiting the period over which any Benefits may be granted,
shall continue in full force and effect until terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <U>Termination</U>. The Plan will terminate automatically on May&nbsp;23,
2027. In addition, the Plan may be terminated at any time by the Board. The Plan will remain in effect with respect to outstanding Benefits until no Benefits remain outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <U>Affect on Benefits</U>. Subject to the provisions of Section&nbsp;6.4, the amendment or termination of the Plan shall not adversely
affect a Participant&#146;s right to any Benefit granted prior to such amendment or termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <U>General Modification Rules</U>.
Any Benefit granted may be converted, modified, forfeited or canceled, in whole or in part, by the Board if and to the extent permitted in the Plan or applicable Agreement or with the consent of the Participant to whom such Benefit was granted. The
Board, in its sole discretion, may accelerate the vesting of a Benefit at any time. The Board may, for such consideration (if any) as it may deem adequate and with the prior consent of the Participant, modify the terms of any outstanding Option or
stock appreciation rights; provided, however, that except to the extent permitted by Section&nbsp;6.5, no Option or stock appreciation right may be repriced, replaced or regranted through cancellation, or by lowering the exercise price of such
Option or stock appreciation right, and no Option or stock appreciation right with an exercise price that exceeds Fair Market Value of a share of Common Stock shall be canceled, purchased or exchanged for a cash payment, without shareholder
approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5 <U>Special Modification in the Event of a Corporate Transaction</U>. In the event of a corporate transaction (within the
meaning of Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.424-1(a)(3)),</FONT> the Board may provide for the assumption or substitution of outstanding Options or stock appreciation rights, provided that the requirements of Treas. Reg. &#167;
1.409A- 1(b)(v)(D) are satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6 <U>Replacement of Benefits</U>. The Board may permit a Participant to elect to surrender a Benefit
in exchange for a new Benefit. Options known as &#147;reload stock options&#148; and other automatic grants to Participants are prohibited under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.7 <U>No Discounted Options; No Repricing</U>. Options may not be granted with an exercise price lower than the Fair Market Value of the
underlying Shares on the grant date (except to the extent awards are assumed or substituted in connection with a corporate transaction as described in Section&nbsp;6.5). The exercise price of an Option shall not be reduced after grant, including by
reason of cancellation, cash buyout or exchange of an underwater Option, without shareholder approval. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE Vll </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CHANGE OF CONTROL </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.1 <U>Right of
Board</U>. In order to maintain a Participant&#146;s rights in the event of a Change in Control, the Board, in its sole discretion, may, in any Agreement evidencing a Benefit, or at any time prior to, simultaneously with or after a Change in
Control, provide such protection as it may deem necessary. Without, in any way, limiting the generality of the foregoing provisions or requiring any specific protection, the Board may: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) provide for the acceleration of any time periods relating to the exercise or realization of such Benefit so that such Benefit may be
exercised or realized in full on or before a date fixed by the Board; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) provide for the purchase of such Benefit, upon the
Participant&#146;s request, for an amount of cash equal to the amount which could have been attained upon the exercise or realization of such Benefit had such Benefit been currently exercisable or payable; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) make such adjustment to the Benefits then outstanding as the Board deems appropriate to reflect such transaction or change; and/or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) cause the Benefits then outstanding to be assumed, or new Benefits substituted therefor, by the surviving corporation in such change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE Vlll </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TERMS AND
CONDITIONS OF BENEFITS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <U>Grant Evidenced by Agreement</U>. The grant of any Benefit under the Plan may be evidenced by an
Agreement that describes the specific Benefit granted and the terms and conditions of the Benefit. The granting of any Benefit may be subject to, and conditioned upon, the recipient&#146;s execution of any Agreement to the extent required by the
Board. All capitalized terms used in an Agreement shall have the same meaning as in the Plan, except as otherwise provided in the Agreement. An Agreement shall be subject to all of the terms of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Provisions of Agreement</U>. Each Agreement shall contain such provisions that the Board shall determine to be necessary, desirable and
appropriate for the Benefit granted which may include, but not be limited to, the following with respect to any Benefit: description of the type of Benefit; the Benefit&#146;s duration; its transferability; if an Option, the exercise price, the
exercise period and the person or persons who may exercise the Option; the effect upon such Benefit of the Participant&#146;s death or termination of employment; the Benefit&#146;s conditions; when, if and how any Benefit may be forfeited, converted
into another Benefit, modified, exchanged for another Benefit, replaced or transferred; and the restrictions on any Shares purchased or granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <U>Non-Transferability</U>. Except as otherwise expressly provided in an Agreement, any Benefit granted to an individual who is subject to
Section&nbsp;16 of the Exchange Act shall be not transferable other than by will or the laws of descent and distribution and shall be exercisable during his lifetime only by him, his guardian or his legal representative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <U>Fair Market Value</U>. If the number of any Stock Based Awards to be granted is determined based on the value of the Common Stock, such
number shall be determined using a value not less than the Fair Market Value of a Share as of the Date of Grant, and the per share exercise price of any Option awarded under the Plan shall not be less than the Fair Market Value of a Share as of the
Date of Grant (except to the extent awards are assumed or substituted in connection with a corporate transaction as described in Section&nbsp;6.5 above). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <U>Tandem Awards</U>. Awards may be granted by the Board in tandem. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IX </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>PAYMENT,
DIVIDENDS, DEFERRAL AND WITHHOLDING </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <U>Payment by Participant</U>. Upon the exercise of an Option or in the case of any other
Benefit that requires a payment to the Company, the amount due the Company is to be paid: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in cash; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by the tender to the Company of Shares owned by the Participant and registered in his name having a Fair Market
Value equal to the amount due to the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in other property, rights and credits, including the Participant&#146;s promissory note if permitted under
applicable law; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by net exercise; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by any combination of the payment methods specified in (a), (b), (c) and (d)&nbsp;above. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, any method of payment other than cash may be used only with the consent of the Board or if and to the extent so provided in an
Agreement or the terms of an award. The proceeds of the sale of Common Stock purchased pursuant to an Option and any payment to the Company for other Benefits shall be added to the general funds of the Company or to the Shares held in treasury, as
the case may be, and used for the corporate purposes of the Company as the Board shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <U>Dividend Equivalents</U>. Grants
of Stock Based Awards may include dividend equivalent payments or dividend credit rights. The payment of dividend equivalents or dividend credits attributable to an unvested Benefit is not permitted during the period in which the Benefit is
unvested. Dividend equivalents and dividend credits may be accumulated during the vesting period of the underlying Benefit and paid out only to the extent the Benefit has vested. Additionally, Participants holding Options or stock appreciation
rights shall not be granted dividend equivalent or dividend credits for any period prior to the exercise of such Option or stock appreciation right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <U>Deferral</U>. Unless otherwise specified by the Board, a Participant may elect, with respect to any Plan Year, to receive a grant of
Performance Units in lieu of another Stock Based Award by making and filing with the Board a written irrevocable election prior to the beginning of such Plan Year (or, in the case of a person who becomes a Participant after the beginning of a Plan
Year, within 30 calendar days after becoming a Participant). Unless otherwise specified by the Board, shares subject to a Participant&#146;s deferral election under this Section&nbsp;9.3 shall count against Shares granted pursuant to the Phantom
Plan and shall not be counted against the Share reserve of this Plan. Shares deferred pursuant to this Section&nbsp;9.3 that are counted under the Phantom Plan shall be governed by the terms and conditions of the Phantom Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <U>Withholding</U>. The Company, at the time any distribution is made under the Plan,
whether in cash or in Shares, may withhold from such distribution any amount necessary to satisfy any federal, state and local income tax withholding requirements with respect to such distribution. Such withholding may be in cash or in Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE </U>X </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OPTIONS
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1 <U>Authorization</U>. The Board may grant Options upon such terms and conditions as the Board may determine. Each Option shall
be evidenced by an Agreement. In no event may Options known as &#147;reload options&#148; or other automatic grants to Participants be granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2 <U>Exercise Price</U>. The per share exercise price of any Option awarded under the Plan shall not be less than the Fair Market Value of
a Share of Common Stock as of the Date of Grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3 <U>Payment of Exercise Price</U>. The payment of the exercise price for Shares
under an Option shall be made in accordance with Section&nbsp;9.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE Xl </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RESTRICTED STOCK </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.1
<U>Authorization</U>. The Board may grant Benefits as Restricted Stock. Shares of Restricted Stock shall be issued and delivered at the time of the grant. Each certificate representing Shares of Restricted Stock shall bear a legend referring to the
Plan and the risk of forfeiture of the Shares and stating that such Shares are nontransferable until all restrictions have been satisfied and the legend has been removed. The grantee shall be entitled to full voting and dividend rights with respect
to all shares of Restricted Stock from the Date of Grant; provided, however, that dividend payments may be accumulated during the vesting period and paid out only to the extent the Restricted Stock has vested. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 <U><FONT STYLE="white-space:nowrap">Non-Transferability</FONT></U>. Shares of Restricted Stock shall not be transferable until after the
removal of the legend with respect to such Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE Xll </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>PERFORMANCE UNITS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1
<U>Authorization</U>. The Board may grant Performance Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2 <U>Number</U>. Unless otherwise approved by the Board or as set forth
in an Agreement, the number of Performance Units granted in lieu of the payment of a director&#146;s meeting fee or retainer shall equal the number of Shares of Common Stock determined by dividing the amount of the applicable meeting fee or retainer
by the Fair Market Value of a Share on the Date of Grant, rounding up to the nearest whole Share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.3 <U>Administration</U>. Any
Performance Units granted to a Participant shall be credited to a Performance Unit Account (the &#147;Account&#148;) established and maintained for such Participant. A Participant&#146;s Account shall be the record of Performance Units granted to
the Participant under the Plan, is solely for accounting and recordkeeping purposes and shall not require a segregation of any Company assets or the setting aside for registering in the name of a Participant any Common Stock. The Performance Units
shall be allocated to a Participant&#146;s Account by the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Board on the business day following the Date of Grant of such Performance Units. Each allocation of Performance Units under the Plan to a participant under the Plan and the number and value of
such Performance Units as of the date of allocation shall be communicated by the Board in writing to the participant within thirty (30)&nbsp;days after the date of allocation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.4 <U>Terms and Conditions</U>. The grant of Performance Units shall be subject to the terms and conditions set forth in the applicable
Agreement.&nbsp;&nbsp;&nbsp;&nbsp;If a Participant shall be determined, in the sole judgment of the Board, to be guilty of Malfeasance, such Participant shall forfeit all rights to the Performance Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.5 <U>Payment</U>. At the end of any imposed restricted or deferral period, if applicable, the Participant shall be entitled to receive from
the Company, with respect to each Performance Unit, either (i)&nbsp;cash equal to the Fair Market Value of a Share at that time, or (ii)&nbsp;one Share; provided that unless otherwise approved by the Board, a Performance Unit representing a partial
Share shall be paid only in cash. A Participant will not be entitled to receive any earnings on the value of his or her Performance Units with respect to the period between the end of the applicable restricted or deferral period and the receipt of
payment under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE Xlll </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OTHER BENEFITS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.1
<U>Other Stock Based Awards</U>. The Board shall have the right to grant other Stock Based Awards which may include, without limitation, the grant of Shares based on certain conditions, the payment of cash based on the performance of the Common
Stock, and the grant of securities convertible into Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.2 <U>Other Benefits</U>. The Board shall have the right to provide types
of Benefits under the Plan in addition to those specifically listed, if the Board believes that such Benefits would further the purposes for which the Plan was established. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XIV </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MISCELLANEOUS PROVISIONS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.1 <U>Underscored References</U>. The underscored references contained in the Plan are included only for convenience, and they shall not be
construed as a part of the Plan or in any respect affecting or modifying its provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.2 <U>Number and Gender</U>. The masculine and
neuter, wherever used in the Plan, shall refer to either the masculine, neuter or feminine; and, unless the context otherwise requires, the singular shall include the plural and the plural the singular. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.3 <U>Governing Law/Venue</U>. This Plan shall be construed and administered in accordance with the laws of the State of Missouri, without
giving regard to the conflict of laws provisions thereof. Any legal action against the Plan, the Company, an Affiliate, or the Board may only be brought in the Circuit Court in St. Louis County and/or the United States District Court in St. Louis,
Missouri. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.4 <U>Purchase for Investment</U>. The Board may require each person purchasing Shares pursuant to an Option or other award
under the Plan to represent to and agree with the Company in writing that such person is acquiring the Shares for investment and without a view to </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distribution or resale. The certificates for such Shares may include any legend which the Board deems appropriate to reflect any restrictions on transfer. All certificates for Shares delivered
under the Plan shall be subject to such stock-transfer orders and other restrictions as the Board may deem advisable under all applicable laws, rules and regulations, and the Board may cause a legend or legends to be put on any such certificates to
make appropriate references to such restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.5 <U>No Effect on Other Benefits</U>. Payments and other benefits received by a
Participant under a Benefit pursuant to this Plan shall not have any effect on the determination of benefits under any other employee benefit plan (including any benefits awarded under the Company&#146;s Phantom Plan), contract or similar
arrangement provided by the Company or an Affiliate, unless expressly so provided by such other plan, contract or arrangement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.6
<U>Rights as Shareholders</U>. A Participant shall have no right as a shareholder with respect to any securities covered by a Benefit until the date the Participant becomes the holder of record. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.7 <U>Date of Grant</U>. The date and time of approval by the Board of the granting of a Benefit shall be considered the date and time at
which such Benefit is made or granted, or such later effective date as determined by the Board, notwithstanding the date of any Agreement with respect to such Benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.8 <U>Beneficiary Upon Participant&#146;s Death</U>. To the extent that the transfer of a Participant&#146;s Benefit at death is permitted
by this Plan or under an Agreement, (i)&nbsp;a Participant&#146;s Benefit shall be transferable to the beneficiary, if any, designated on forms prescribed by and filed with the Board and (ii)&nbsp;upon the death of the Participant, such beneficiary
shall succeed to the rights of the Participant to the extent permitted by law and this Plan. If no such designation of a beneficiary has been made, the Participant&#146;s legal representative shall succeed to the Benefits, which shall be
transferable by will or pursuant to laws of descent and distribution to the extent permitted by this Plan or under an Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.9
<U>Unfunded Plan</U>. This Plan shall be unfunded and the Company shall not be required to segregate any assets that may at any time be represented by Benefits under this Plan. Neither the Company, its Affiliates, nor the Board shall be deemed to be
a trustee of any amounts to be paid under this Plan nor shall anything contained in this Plan or any action taken pursuant to its provisions create or be construed to create a fiduciary relationship between the Company and/or its Affiliates, and a
Participant or successor. To the extent any person acquires a right to receive a Benefit under this Plan, such right shall be no greater than the right of an unsecured general creditor of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.10 <U>Severability</U>. In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or
invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d173454dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PHANTOM STOCK PLAN FOR DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As Amended and Restated Effective May&nbsp;19, 2021 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REINSURANCE GROUP OF AMERICA, INCORPORATED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PHANTOM STOCK PLAN FOR DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE I </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NAME AND
PURPOSE </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Name</U>. The name of this Plan is the &#147;Reinsurance Group of America, Incorporated Phantom Stock Plan for
Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Purpose</U>. The Company has established this Plan to encourage the highest level of director performance by
members of the Board of Directors of the Company, by providing certain outside directors with deferred compensation based on the Company&#146;s success and progress. The Plan is hereby amended and restated as provided herein and shall be effective
with respect to amounts deferred on or after May&nbsp;19, 2021, except with respect to Section&nbsp;7.4, which apply to outstanding Performance Units granted at any time under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE II </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DEFINITIONS
OF TERMS AND RULES OF CONSTRUCTION </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>General Definitions</U>. The following words and phrases, when used in the Plan, unless
otherwise specifically defined or unless the context clearly otherwise requires, shall have the following respective meanings: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Account</U>. Account shall have the meaning given such term in ARTICLE VI. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Affiliate</U>. A Parent or Subsidiary of the Company, a Subsidiary of a Parent and any limited liability
company, partnership, corporation, joint venture, or any other entity in which the Company or any such Subsidiary owns an equity interest. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Board</U>. The Board of Directors of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Code</U>. The Internal Revenue Code of 1986, as amended and in effect from time to time, or any successor
statute. Any reference to the Code includes the regulations promulgated pursuant to the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Common Stock</U>. Any class of the Company&#146;s common stock or any securities issued in respect thereof
by the Company or any successor to the Company as a result of an event described in ARTICLE X and Section&nbsp;11.10 hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Company</U>. Reinsurance Group of America, Incorporated, a Missouri corporation, or any successor to all or
substantially all of its business by merger, consolidation, purchase of assets or otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Deferral Period</U>. Deferral Period shall have the meaning given such term in Section&nbsp;5.3.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Director</U>. A duly elected and acting member of the Board who receives Director&#146;s Fees from the
Company for his or her services as a member of the Board and who is not an officer or employee of the Company or any of its Affiliates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Director&#146;s Fees</U>. Any and all of the following, whether payable in cash or Common Stock:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Annual retainer fees for services as a Director (including retainers paid to Board and Committee chairs);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Board and Committee meeting attendance fees; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any other form of compensation (including cash, equity grants or performance units) paid to a Director for
service as a member of the Board, a Committee or a Board <FONT STYLE="white-space:nowrap">sub-group.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Disability</U>. A physical or mental condition which, in the opinion of a qualified doctor of medicine
chosen by the Company, permanently prevents a Director from carrying out his or her duties as a member of the Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Dividend Equivalents</U>. Dividend Equivalents shall have the meaning given such term in Section&nbsp;7.4.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Effective Date</U>. The date that the Plan, as amended and restated herein, is approved by the shareholders
of the Company which must occur within one year before or after approval by the Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Fair Market Value</U>. The closing price of a share of Common Stock on the New York Stock Exchange on a
given date, or in the absence of market transactions on such date, the closing price of a share of Common Stock on the New York Stock Exchange on the last day on which a sale occurred prior to such date. If the shares are not listed on the New York
Stock Exchange, Fair Market Value shall be what the Board determines in good faith to be 100% of the fair market value of a share on that date. The determination of Fair Market Value shall be subject to adjustment as provided in ARTICLE X.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Parent</U>. Any corporation that is a &#147;parent corporation,&#148; as that term is defined in
Section&nbsp;424(e) of the Code, or any successor provision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Participant</U>. A Director who has satisfied the eligibility requirements of Section&nbsp;4 and who has
Performance Units credited to his or her Account. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Performance Unit</U>. A hypothetical share of Common Stock allocated to a Participant on the Company&#146;s
records based on the Fair Market Value of the Common Stock at the time of the grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Plan</U>. Plan shall have the meaning given such term in ARTICLE I. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Plan Year</U>. The calendar year. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Retirement</U>. Retirement of a Participant as a Director. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(t)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Subsidiary</U>. Any corporation that is a &#147;subsidiary corporation,&#148; as that term is defined in
Section&nbsp;424(f) of the Code, or any successor provision. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Other Definitions</U>. In addition to the above
definitions, certain words and phrases used in the Plan may be defined in other portions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE III </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ADMINISTRATION </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Board</U>. The Board shall administer the Plan. Questions involving eligibility, benefits or the interpretation or operation of the Plan shall be referred to the Board. All determinations of the Board, in its sole discretion, shall be conclusive.
The Board may obtain such advice or assistance as it deems appropriate from persons not serving on the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Expenses</U>. All
costs and expenses incurred in the operation and administration of this Plan will be borne by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IV </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ELIGIBILITY </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1
<U>Participants</U>. Each Director who is a Participant on May&nbsp;23, 2017 shall continue to be a Participant as of such date. Each individual who becomes a Director on or after May&nbsp;23, 2017 shall be eligible to participate as of the
beginning of the next Plan Year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE V </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>PERFORMANCE UNITS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1
<U>Number of Performance Units</U>. The total number of Performance Units that may be granted under this Plan shall not exceed 155,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Election to Receive and Defer Performance Units</U>. With respect to each Plan Year, a Participant shall be eligible to receive a grant
of Performance Units in lieu of all or any portion of his or her Director&#146;s Fees by making and filing with the Board a written election by the date specified by the Company, which shall be no later than the December&nbsp;31 prior to the first
day of the Plan Year in which such Director&#146;s Fees would otherwise be earned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Deferral Period</U>. A Participant who elects
to receive a grant of Performance Units in lieu of his or her Director&#146;s Fees for any Plan Year under Section&nbsp;5.2 shall also be eligible at such time to elect to defer payment of such Performance Units (i)&nbsp;for a period of five
(5)&nbsp;or seven (7)&nbsp;years from the last day of the calendar year in which a Performance Unit is granted or (ii)&nbsp;to Retirement (&#147;Deferral Period&#148;). The Participant shall designate to receive payment of such
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Performance Units in a single payment or up to five substantially equal annual installment payments. With respect to each grant of Performance Units, a Participant may elect a different Deferral
Period and manner of payment hereunder. A Participant who does not affirmatively elect a Deferral Period shall be deemed to have elected a Deferral Period until Retirement with distribution to be made in a single payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Irrevocability</U>. Any election (or deemed election) under ARTICLE V with respect to a Performance Unit shall become irrevocable as of
the December&nbsp;31 prior to the first day of the calendar year in which such Performance Unit is granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Changes</U>. In
accordance with the provisions of this Section&nbsp;5.5, a Participant may change the Deferral Period and/or the form of payment for Performance Units which relate to a particular year by making a <FONT STYLE="white-space:nowrap">re-deferral</FONT>
election and/or an election to have such Performance Units paid in a different form. Any election under this Section&nbsp;5.5 must comply with all of the following requirements: (i)&nbsp;no prior election to change the Deferral Period or form of
payment may have been made with respect to the same year&#146;s deferrals, (ii)&nbsp;the election is made at least one year prior to the date the distribution would otherwise have begun, (iii)&nbsp;the first payment with respect to which such
election is made shall be deferred for a period of not less than five years from the date such payment would otherwise have been made, and (iv)&nbsp;any election related to a payment that was otherwise to be made at a specified time may not be made
less than twelve months prior to the date of the first scheduled payment. For purposes of applying the provisions of this Section&nbsp;5.5, installment payments shall be considered a single payment for purposes of applying these subsequent deferral
election rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VI </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ACCOUNTS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1
<U>Performance Unit Accounts</U>. Performance Units shall be credited to a Performance Unit Account (the &#147;Account&#148;) established and maintained for a Participant. The Performance Units shall be allocated to a Participant&#146;s Account
annually on the same day the annual equity grant is made to Directors, unless the Board approves a different allocation date. The number of Performance Units shall equal the number of full shares of Common Stock that the amount of the deferred
Director&#146;s Fees would have purchased at Fair Market Value on the allocation date. Partial Performance Units will not be allocated, and standard rounding will be applied to determine the number of full Performance Units. The Account of a
Participant shall be the record of Performance Units granted to him or her under the Plan, is solely for accounting and record keeping purposes and shall not require a segregation of any Company assets or setting aside for or registering in the name
of a Participant any Common Stock. In addition, the existence of such record and the Account shall not be deemed to create a trust of any kind or a fiduciary relationship between the Company and a Participant or his or her beneficiary. Each
allocation of Performance Units under the Plan to a Participant and the number and value of such Performance Units as of the date of allocation shall be communicated annually to the Participant. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RESTRICTIONS AND PAYMENTS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Restrictions</U>. The Participant shall have no rights and privileges of a shareholder as to the Performance Units credited to his or
her Account. Accordingly, the Participant shall have no right to receive dividends actually paid or distributed at the time declared (other than Dividend Equivalents granted under Section&nbsp;7.4) and no right to vote on account of any allocation
of Performance Units to his or her Account. In addition, no interest in the Performance Units or any Account may be sold, transferred, assigned, pledged or otherwise encumbered or disposed of at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Payment of Performance Units</U>. Except as otherwise provided under this ARTICLE VII, distribution of the Performance Units shall
occur (or commence in the case of annual installments) on the date immediately following the last day of the applicable Deferral Period. Distribution shall be made in a single payment, unless at the time of deferral the Participant had elected to
receive payment in annual installments. The Board shall have the sole discretion to determine whether such distribution shall be made in cash or in stock. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Lump Sum Payments</U>. If distribution shall be made in a single lump sum, the amount of the distribution
shall equal (i)&nbsp;the Fair Market Value of a share of Common Stock as of the last day of the Deferral Period multiplied by the number of Performance Units credited to his or her account on such date, or (ii)&nbsp;one share of Common Stock in lieu
of cash for each Performance Unit credited to his or her account on the last day of the Deferral Period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Annual Installments</U>. If distribution shall be made in annual installments, the amount of each
installment shall equal (i)&nbsp;the Fair Market Value of a share of Common Stock as of the last day of the Deferral Period (or the applicable annual anniversary thereof), multiplied by the number of Performance Units being distributed in such
installment, or (ii)&nbsp;one share of Common Stock in lieu of cash for each Performance Unit being distributed in that installment. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>End of Directorship</U>. If a Participant ceases to be a Director prior to the end of the Deferral Period, distribution of all
Performance Units allocated to such Participant&#146;s Account shall be made or commence at the time and in the form of payment elected or deemed to have been elected at the time of deferral. Payment shall be made to the Participant, the
Participant&#146;s beneficiary in the event of death, or the Participant&#146;s estate in the case of Disability if there is no <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> as the case may be.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Tax</U>. In all cases, for purposes of compliance with Section&nbsp;409A of the Code, payment shall be deemed to be made upon the
fixed date or payment event specified under Section&nbsp;7.2(b) if the payment is made (a)&nbsp;thirty (30) days prior to the specified fixed payment date or event; (b)&nbsp;a later date within the same calendar year as the specified fixed payment
date or event; or (c)&nbsp;if later, by the 15th day of the third calendar month following the specified fixed payment date or event. However, in no event shall a Participant be permitted, directly or indirectly, to designate the taxable year of the
payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>Dividend Equivalents</U>. Grants of Performance Units may include, at the sole
discretion of the Board, Dividend Equivalents on each Performance Unit credited to and accumulated under the Participant&#146;s Account. &#147;Dividend Equivalents&#148; means a dollar amount equal to the cash dividend that the Participant would
have been entitled to receive if the Participant had been the owner, on the record date for a dividend paid on the Common Stock, of a number of shares of Common Stock equal to the number of Performance Units then properly credited to and accumulated
under the Performance Unit Account of the Participant. The payment of Dividend Equivalents attributable to any unvested Performance Units is not permitted during the period in which the Performance Units are unvested. Dividend Equivalents will be
deemed to be reinvested in additional Performance Units on the date a dividend is paid on the Common Stock, and the additional Performance Units will be accumulated and credited to a Participant&#146;s Account on the annual allocation date described
in Section&nbsp;6.1. The number of Performance Units acquired with the Dividend Equivalents shall equal the number of full shares of Common Stock that the amount of the Dividend Equivalents would have purchased at Fair Market Value on the dividend
payment date, and standard rounding will be applied to determine the number of full Performance Units. All Performance Units credited to a Participant&#146;s Account under this Section&nbsp;7.4 shall be paid at the same time, and in the same form,
as elected by the Participant under Section&nbsp;5.3 with respect to the underlying Performance Units in the Participant&#146;s Account. All outstanding grants of Performance Units made prior to May&nbsp;19, 2021 are deemed to include the right to
receive Dividend Equivalents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VIII </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>REGULATORY COMPLIANCE AND LISTING </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <U>Regulatory Compliance</U>. If the Board decides to deliver Common Stock in lieu of cash under ARTICLE VII, the issuance or delivery of
any Common Stock may be postponed by the Company for such period as may be required to comply with any applicable requirements under the federal securities laws, any applicable listing requirements of any national securities exchange and
requirements under any other law or regulation applicable to the issuance or delivery of such shares, and the Company shall not be obligated to issue, purchase or deliver any Common Stock if the issuance, purchase or delivery of such shares shall
constitute a violation of any provision of any law or of any regulation of any governmental authority or any national securities exchange. If the Company is unable to deliver Common Stock after a reasonable period of time, the Board shall direct the
delivery of cash under ARTICLE VII to satisfy the distribution of Performance Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Other Agreements</U>. As a condition to
receipt of Common Stock, the Participant shall execute such agreements and other documents as the Company may reasonably request for securities law purposes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IX </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AMENDMENT, TERM AND TERMINATION </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <U>Amendment</U>. Except as hereinafter provided, the Board shall have the sole right and power to amend the Plan at any time and from
time to time. No termination, suspension or modification of this Plan may materially and adversely affect any right acquired by any Participant (or a Participant&#146;s legal representative) or any successor or permitted transferee under a
Performance Unit granted before the date of termination, suspension or modification, unless otherwise provided in a separate agreement or otherwise or required as a matter of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <U>Limitation</U>. The Board may not amend the Plan (i)&nbsp;without approval of the shareholders of the Company if shareholder approval
would be required for such an amendment under the rules of the New York Stock Exchange or (ii)&nbsp;in a manner that would violate applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <U>Term</U>. The original effective date of the Plan was January&nbsp;1,&nbsp;1997 and the Plan as amended and restated herein shall
commence as of the Effective Date and, subject to the terms of the Plan, including those requiring approval by the shareholders of the Company, shall continue in full force and effect until terminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <U>Termination</U>. The Plan will terminate automatically on May&nbsp;23,&nbsp;2027. In addition, the Board may at any time terminate the
Plan unless otherwise required by law, the rights of a Participant with respect to Performance Units granted prior to such termination may not be impaired without the consent of such Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE X </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ADJUSTMENTS
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1 <U>Adjustment</U>. In the event of any change in the Common Stock of the Company by reason of any extraordinary dividend, stock
dividend, <FONT STYLE="white-space:nowrap">spin-off,</FONT> <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-out,</FONT> recapitalization, warrant or rights issuance or combination, exchange or reclassification
of shares, merger, consolidation, reorganization, sale of substantially all assets or, in the Board&#146;s sole discretion, other similar or relevant event, the Board shall proportionately adjust, in an equitable manner, the total number of
Performance Units which may be granted under the Plan under ARTICLE V and the number of Performance Units held by a Participant under the Plan and, if appropriate to reflect such event and preserve the value of such Performance Units, the number,
kind and class of shares underlying the Performance Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE XI </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MISCELLANEOUS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.1
<U>Underscored References</U>. The underscored references contained in the Plan are included only for convenience, and they shall not be construed as a part of the Plan or in any respect affecting or modifying its provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 <U>Number and Gender</U>. The masculine and neuter, wherever used in the Plan, shall refer to either the masculine, neuter or feminine;
and, unless the context otherwise requires, the singular shall include the plural and the plural the singular. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3 <U>Governing Law/Venue</U>. This Plan shall be construed and administered in accordance
with the laws of the State of Missouri, without giving regard to the conflict of laws provisions thereof. Any legal action against the Plan, the Company, an Affiliate, or the Board may only be brought in the Circuit Court in St. Louis County and/or
the United States District Court in St. Louis, Missouri. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.4 <U>No Director Reelection</U>. Nothing in the Plan shall be deemed to
create any obligation on the part of the Board to nominate any Director for reelection by the Company&#146;s shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.5
<U>Limitations</U>. Neither the adoption of this Plan by the Board nor the submission of the Plan to the Company&#146;s shareholders for approval shall be construed as creating any limitations on the power or authority of the Board to adopt such
other additional incentive or other compensation arrangements as the Board may deem necessary or desirable </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.6 <U>Deductions</U>. The
Company shall have the right to (i)&nbsp;deduct from all amounts paid pursuant to the Plan any taxes required by law to be withheld with respect to such amounts, and (ii)&nbsp;require, within three months after issuance or delivery of any Common
Stock, payment by the Participant of any taxes required by law with respect to the issuance or delivery of such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.7
<U>Designation of Beneficiary</U>. Each Participant may designate one or more beneficiaries to receive all payments due to such Participant hereunder upon his or her death. Such beneficiary designation may be revoked or amended by such Participant,
from time to time, by appropriate notice in writing delivered to the General Counsel of the Company. In the absence of any beneficiary designation or in the event that the designated beneficiaries shall not be living at the time of death of the
Participant, the Account value on the date of death of the Participant shall be payable and delivered to the estate of such deceased Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.8 <U>Common Stock</U>. The shares of any Common Stock delivered under the Plan may be either authorized but unissued shares (subject to
payment of any required par value) or treasury shares, as determined from time to time by the Board. In either case, the shares shall be fully registered and transferable without restriction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.9 <U>Assignment</U>. No rights, interests or benefits under this Plan may be assigned, transferred, pledged or hypothecated in any way.
Such rights, interests or benefits shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge or hypothecation, or other disposition of such rights, interests or benefits contrary to the preceding
provisions, or the levy of any attachment or similar process thereupon, shall be null and void and without effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.10 <U>Successors
and Assigns</U>. This Plan shall be binding upon and inure to the benefit of the successors and assigns of the Company, whether by way of merger, consolidation, operation of law, assignment, purchase or other acquisition of substantially all of the
assets or business of the Company and any such successor or assign shall absolutely and unconditionally assume all of the Company&#146;s obligations hereunder. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.11 <U>No Equitable Rights</U>. The payments to a Participant or his or her beneficiary
hereunder shall be made from assets which shall continue, for all purposes, to be part of the general, unrestricted assets of the Company. No person shall have any interest in any such assets by virtue of the provisions of the Plan. The
Company&#146;s obligation hereunder shall be an unfunded and unsecured promise to pay money in the future. To the extent that any person acquires a right to receive payments from the Company under the provisions hereof, such right shall be no
greater than the right of any unsecured general creditor of the Company. No such person shall have nor acquire any legal or equitable right, interest or claim in or to any property or assets of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.12 <U>Tax Compliance</U>. Payments and benefits under this Plan are intended to comply with Code Section&nbsp;409A to the extent subject
thereto, and, accordingly, to the maximum extent permitted, this Plan shall be interpreted and administered to be in compliance therewith. For purposes of Code Section&nbsp;409A, a Participant&#146;s entitlement to annual installment payments shall
be treated as an entitlement to a single payment. For purposes of this Plan, a termination of directorship or Retirement shall only be deemed to occur if such termination constitutes a &#147;separation from service&#148; within the meaning of Code
Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.13 <U>Severability</U>. In the event any provision of this Plan shall be held illegal or invalid for any reason,
the illegality or invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rga-20210519.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 5/21/2021 12:07:39 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:rga="http://www.rgare.com/20210519"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.rgare.com/20210519"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" namespace="http://fasb.org/us-gaap/2019-01-31" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" namespace="http://fasb.org/us-types/2019-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rga-20210519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rga-20210519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rga-20210519_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="rga_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="rga_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" name="M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" name="M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>rga-20210519_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 5/21/2021 12:07:45 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rga-20210519.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="rga-20210519.xsd#rga_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="rga_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="rga-20210519.xsd#rga_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="rga_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="rga-20210519.xsd#rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" xlink:type="locator" xlink:label="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" />
    <link:loc xlink:href="rga-20210519.xsd#rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" xlink:type="locator" xlink:label="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="rga_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rga_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>rga-20210519_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 5/21/2021 12:07:39 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="rga-20210519.xsd#rga_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="rga_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rga_DocumentAndEntityInformationTable" xlink:to="rga_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="rga_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="rga_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="rga-20210519.xsd#rga_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="rga_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="rga_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="rga_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="rga_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="rga-20210519.xsd#rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" xlink:type="locator" xlink:label="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" xlink:to="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 6.20 Fixed To Floating Rate Subordinated Debentures Due 2042 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 6.20 Fixed To Floating Rate Subordinated Debentures Due 2042 [Member]</link:label>
    <link:loc xlink:href="rga-20210519.xsd#rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" xlink:type="locator" xlink:label="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" xlink:to="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 5.75 Fixed To Floating Rate Subordinated Debentures Due 2056 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 5.75 Fixed To Floating Rate Subordinated Debentures Due 2056 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>rga-20210519_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 5/21/2021 12:07:41 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rga-20210519.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="rga-20210519.xsd#rga_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="rga_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="rga_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="rga-20210519.xsd#rga_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="rga_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationTable" xlink:to="rga_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="rga-20210519.xsd#rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" xlink:type="locator" xlink:label="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="rga-20210519.xsd#rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" xlink:type="locator" xlink:label="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rga_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d173454d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rga="http://www.rgare.com/20210519"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rga-20210519.xsd" xlink:type="simple"/>
    <context id="duration_2021-05-19_to_2021-05-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000898174</identifier>
        </entity>
        <period>
            <startDate>2021-05-19</startDate>
            <endDate>2021-05-19</endDate>
        </period>
    </context>
    <context id="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000898174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-19</startDate>
            <endDate>2021-05-19</endDate>
        </period>
    </context>
    <context id="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000898174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rga:M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-19</startDate>
            <endDate>2021-05-19</endDate>
        </period>
    </context>
    <context id="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000898174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rga:M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-19</startDate>
            <endDate>2021-05-19</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2021-05-19_to_2021-05-19"
      id="Hidden_dei_EntityRegistrantName">REINSURANCE GROUP OF AMERICA INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2021-05-19_to_2021-05-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-05-19_to_2021-05-19"
      id="Hidden_dei_EntityCentralIndexKey">0000898174</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-05-19_to_2021-05-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-05-19_to_2021-05-19">2021-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-05-19_to_2021-05-19">MO</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-05-19_to_2021-05-19">1-11848</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-05-19_to_2021-05-19">43-1627032</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-05-19_to_2021-05-19">16600 Swingley Ridge Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-05-19_to_2021-05-19">Chesterfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-05-19_to_2021-05-19">MO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-05-19_to_2021-05-19">63017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-05-19_to_2021-05-19">(636)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-05-19_to_2021-05-19">736-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-05-19_to_2021-05-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-05-19_to_2021-05-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-05-19_to_2021-05-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-05-19_to_2021-05-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">RGA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member">6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member">RZA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member">5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member">RZB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-05-19_to_2021-05-19_us-gaap-StatementClassOfStockAxis_rga-M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-05-19_to_2021-05-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140696545359960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rga_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">REINSURANCE GROUP OF AMERICA INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000898174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 19,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">MO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">43-1627032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">16600 Swingley Ridge Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chesterfield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">63017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(636)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">736-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rga_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RGA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member', window );">M 6.20 Fixed To Floating Rate Subordinated Debentures Due 2042 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rga_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RZA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member', window );">M 5.75 Fixed To Floating Rate Subordinated Debentures Due 2056 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rga_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RZB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rga_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rga_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rga_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M PRD=&&*&V@1K]%+L&8);"&./5)9A&Y_GX\PHM*%J64O3?Q3ZL#F\H6'L-V
MYR?)<@.<F0X_SQ920>C@&#;K? &UE4&;)5>0'NJT::WR+>V7]MZE?$M_I;@?
MUBQ?7,3$[Z== )OWLEDO@.$^@-AC>FG&'NZ:]O*V",P>L?+V2M/U<(^L7]X6
M(4MY>Z77>KC73DCGM-OYMO+N^'7*VSMXG?(N[NR5[NQ]#W>VB)CX?6-Y=WSL
M-DKW]OZO>UL$9H^7&$CIWM[W<F^+T+'R;AV\NS3O@2?,;%Y2$O$EZ#B0B091
MNU>KNQ,M-_GKS(746L;YX9HSV(&9"^#WI93Z[<2\(2U><%_\!5!+ P04
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MJ'7N0;#W\!J-'<V/'[?\ 5!+ P04    " !#B+12)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 0XBT4F60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" !#B+12!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( $.(M%*2Q13?[P   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $.(M%*97)PC
M$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ 0XBT4G*XA<40!0  [!8  !@              ("!#@@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $.(M%*?H!OP
ML0(  .(,   -              "  50-  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ 0XBT4I>*NQS     $P(   L              ( !,!   %]R96QS
M+RYR96QS4$L! A0#%     @ 0XBT4APX9>H_ 0  / (   \
M ( !&1$  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $.(M%(D'INBK0
M /@!   :              "  842  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( $.(M%)ED'F2&0$  ,\#   3              "
M 6H3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  +04
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d173454d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d173454d8k.htm">d173454d8k.htm</File>
    <File>d173454dex101.htm</File>
    <File>d173454dex102.htm</File>
    <File>d173454dex103.htm</File>
    <File>rga-20210519.xsd</File>
    <File>rga-20210519_def.xml</File>
    <File>rga-20210519_lab.xml</File>
    <File>rga-20210519_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d173454d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "rga-20210519_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "d173454d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rga-20210519_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rga-20210519_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rga-20210519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "rga",
   "nsuri": "http://www.rgare.com/20210519",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d173454d8k.htm",
      "contextRef": "duration_2021-05-19_to_2021-05-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d173454d8k.htm",
      "contextRef": "duration_2021-05-19_to_2021-05-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "rga_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://www.rgare.com/20210519",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "rga_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://www.rgare.com/20210519",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "rga_M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 5.75 Fixed To Floating Rate Subordinated Debentures Due 2056 [Member]",
        "terseLabel": "M 5.75 Fixed To Floating Rate Subordinated Debentures Due 2056 [Member]"
       }
      }
     },
     "localname": "M5.75FixedToFloatingRateSubordinatedDebenturesDue2056Member",
     "nsuri": "http://www.rgare.com/20210519",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "rga_M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 6.20 Fixed To Floating Rate Subordinated Debentures Due 2042 [Member]",
        "terseLabel": "M 6.20 Fixed To Floating Rate Subordinated Debentures Due 2042 [Member]"
       }
      }
     },
     "localname": "M6.20FixedToFloatingRateSubordinatedDebenturesDue2042Member",
     "nsuri": "http://www.rgare.com/20210519",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.rgare.com//20210519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-21-167916-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-167916-xbrl.zip
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M9UC_L+!^0RF5:XI6WGOXNM)0E7KJNWUVB/2K2J.T5V=C;\'KZM(3Q4EDZ]&
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M3,[<8]$:\Y\:4Z8AI7T"AHLAQ 4::7@J( 3 VJ/X@<O\X?#A2DY\5+SI)?>
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M;EAPBKLI.&^2M$3"G$^FCGY'1@4G/:.LJ"A14:8CCE]P4B<2-@.\[[^+\I-
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M>UV<N2NN*@#D$ACC7#E:HZ[8E)+=4O:ZEO3M>V2= 0O*:S1ZPBD'/.Q+FQJ
MQTVR=$1*AFX4D&S#8XL)-_%ECEMM-NC!@E@(ZJ#6$CS)R23-T+6-'8% K.G^
MT,UF>ETX9PF 7JMP[:3EJ %G>0=>@SX\JM>C=T63(H@;O-$+#9GAQ1_SE#.
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MT@\FWE'8#MG']N<2\9>\M$X*>[-KKD..]TT1'F@)IE'-B3/L&G!#2IQXEML
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M+YLK;=3(1HNF48D NRJE>)YL-$%I=UWE5*N_*(?MPH"=)ODF:8EXKV$MF,&
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M) ^377P,X[$.<W2K,J-8VUKG+>Z#?5 .,<(V)+AK.HWRG-SU<A\S+6"L;-[
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MS16H!M]:E?T_M,W5SL8VW>Q37>; Z$484D8\FPI .[.(XA>DO!NH/KK <HJ
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MM#MM;>40.?6%WIYM_B@_KQS4N-GUEJST5]W.6B1I-H:IY%Q#DC]0Z?I+1)O
M19F%$0D! DI%5"DZ,7404<?TZ<^HE[MJ+3(S6)63-5"FHR@34U?T4+B216R
MD#(9#6)&6:0AMB,MJ]HNL69/O+,2$9.L]E0-3PF)PUGN"2GFTMQ!>RVZE"69
M=$CQ7-A]6M"%5:ZEQ">A,VFC4ZZQ"+QP.K,UM(A584U'X7C^P8;,'["&0Y26
M.1R2#!XP'(,G2 =@P\K;A].A1VQ]D]#P U,HSA8F6L13<?>N?*J5_@1'I38V
MIKHGD4%6JSZQU/8QO^&U_B8;]GM7</"Q?]0_.S_=6UY[F*?<'J96/;EJT88C
MH'M,X,T:O'T/GJCDR^8U](7TR&Y(2CLXT!'QMDN]!/;ZE#V7>VR/FUHM9XYI
MM/K9 E.<<48F9XFRONK"W=@)O(RM>F/>ZEF ^@;*H%D!3+IJ:O-W;VIC<]=K
M<.3<XI&M@/!D Y,4Z2HD1\AWDWMZ2[UDEFASW8[!_B,9.H Q2-Y58.MGZS)3
M)3UB;8'7927PU7-3@P=]#JPGH+:"6IC5S'7HJ4Z63DFC<B4:JH+A*^=,T%$H
M:FR91-3P!4@?]1R@9L_IMY"<_[YAA]45>XA-3*AN FC?A>E@!-1<ZEKX$FC7
M!A^OH]P5)_Z[]BQ!J#O5=@W8-6]8WQ#]. C>-,S0%>GVX[N&G%:T\Q/V,:E*
M<>JJ*;VT2#Z*JK=B,#]U\P%')$@,_RI!JVIP$6LY5'UB*WKY"<O]3\//3"HU
MO3W,C;RAN,PU9!,HA_4DG)?GU5#HCH2YJ9.T5/$D/[*N80F&<1A-V9\ZL"[B
ME:'ZLU7O-WU_%*9+HZ,#XW9#"PZ,]>@"&R&U,;,5]_H)2^!;>C%4@HYEG5&3
M6>14(SWT7 S ?A"!A#W$5]3R$U9HY\"4@LT39PEAU"S1<_PGLYLP\<$TIM2*
MA<#.RFR6YEQ6T3GZJ0,Q5J)6B4:@-K=#0T=8'F48.U\)LI^O!GH!:E5 E4"D
M&2%#& 7PQ(4R!311"2*]V-A242:HS(@1AE<3;DZ- S0:6:I)B"7037%>QL=%
M4[0 DF)%>3]?#?-1RK*.08(,:!I:<$7$KGSL*EYA5SZHAQ@>:?(2 LY"/[QO
MW9E8CHKZ0BC3,M4R2.]1!D6LZ/!G*XD.^ABBEHEKC31FHR-6ET)(!+.25&-!
M\X':%B&B,T%P#TG4O-#)<,X0/(.P9DB>CPHU=4A@!0FQ2 MWTE_(/6:1HT3R
M5B8_A RJ&V 4!GW8=@OE0 (L<>RU"S,M,RS.8@PCQX$:1 (2XM"$0"\\P]UU
M/G;XL$!\ "2W'*AU,:Q^9V.'4,."_K7E7*Q#P(='(!=*!Z2[\T.CRXA!GXCK
M1%C3D.I"1P6]N;S*H#)$R1O]#..$",>75CJU6G;+P1?]MJPLG;V/O:,#^._Y
M4E)TGC&PZ"2]PE;8"%)P$*/>EZ&>4<T6)E/NO6)K"U'VA,/@5"CKV<;V3= :
M]E*1Y,/)B7 IP.)$EE/&V&G>K(WAEE@M1P[7S;[8.A%7AHT+*LH,UU*".RQ;
M*VYYZSXS7*W*L"JZ81Q>U0^&H7F4#\3#U5&<VQM;:X/UP+6X%A3R=?T)S&],
MJ%Z26^VB)9V5#WZJI<.Y2\4,$>PEN\86*$>I\O@:,GY0:!/#[Z?IJ(+<=D>!
M!SK%OG."QL8S'%W"/2>D,=<T(;PEO^VAI$4)HM=W**Y1<^B6]*!87X2Q*SH5
MHI:]WLRU33/O30#O37),;C19!A96VNT8W(TT%2HF7M>NVQU! (/&5%O>YJ3[
M+PJ.I5):RSU%HE..@$LA@4G+D&<@'.#%E*GL&#[W^,K+*4%.A7 ]D#85Y"<#
M(V>(K8_5=VL:2PZ'4%"N$+PM'3!'J62\7//:&F6<:A9W_8Q7>:0_CCT3\K$-
M0NX8&KV]*NNT8'"C)=B.62:/V._(5<]BB<9^PR[WVZNTC/'>."*VGA9DU[@$
M(DL7;N  N0R_L)%-YF'+*3-9E$,B>9[T,DJQO:67X, W9AD"VPB6^%LE]G<N
M (CWXT:W@__7/R)0\H;Z>'S0?]??9XCRWM&!.NV='.[M]Y:F6#QGQ>(<.*JC
M65 J+U#!O;9A(C#&_PF3$LQ<IHBM0&V]?/G"X219.<@QA](VH3NM-J&S2>_3
M*?=<8OE7[7(7U*5T"X38CY1AXCQ3/JGFM1YTUUTH7CK^GK1U$WB3A%O,<C&M
M8ORL@VI"KTWH01Q!A$WI(\Z/Q$LX9 U)BHAQ$4B7"''_J77/F6^=.WE:0ZU3
MVHM=(5H<\,-":AG V_H8RMO?WH&-;V]NOZCE-UIZD5-RNZTH>,T<)S<]Z&-H
MS;CB:_4$Z[8\&#G<Q(NNRCC>TTNH4_%<DAEY)W""9GFM8/EJ=E=%LWR^\91/
MU_'S-/,UH\IM=>G75G\ K5(4B#9MS@:G?:> S:^N="I;M(!ED#/E=[WGK'/U
MT5>'L8 @'W*WL]>R)Z%/N+5P/H2[9542_V4SF/Q$Z*"M*E)0H63.9:Y[3ISZ
MZY=A85=A:\U76]<:_3=>-K"OZAFH>Z6D"/)HV1]=JF[GACP2LKN&N+V,&XIJ
M=8E %W0 C+V<+^_JUK2<P.D:)G[#Y[_&>=WKXGNPSM)PA"7 "V:,=J=,88OW
M*V]G7I4'9!9ZS$!RW-%NY$1>% ;:-*[BO-A=JW\':@(6[B6F8Y%&H]EHO<:*
MK%W(9P'R&SNI6C2GH36TE:(A3@S_BL.A*9I:SUZ3K#F7&X8&+!KC1D#5TL*E
M\'FW<_-2./GF=JLV?;UJL]FSTJ.\O8)[V%[RSLM:LE?*-*BADS")R:R_AIP'
M*1GQSK'F"70#A0GC9?">9\A[SK#83YWWR#WO7=IBN_NFF(0Z1Q.8PU>56D7:
M/6PK3["]++&N->F^RVY:'29R2\\Q9Q++^X)X V[^_,7N+>JF;CS=?OIX:RU<
M7]M97[=IY56'C-P3%\6P290WY5!Z-0H6WL/ V<&VCW'='=/<6K<#2]]\N?=8
MH9]E[7)][6"=RVY3'81H.4K5<T4U-^A.F_(-53E?M0REOU]8Y^A4<87EK-3B
M\!TDJ! 9VXPO2 *+L+:].?3/\)))#V?74Z;C-!S)>^#.4+DIJI9()7*GYTEN
M$Z[!3PZA(X;W-8D&T:+^4?>L5KW ,S]*U0&(,RDO(R>PBUZS4^*U0(Q\_N9P
MC%WNY7DM8',Q>S\GX?5M-;H=.HN8TG1-;7C^"5<>(4-JK56V2*HQM;K(V9OD
M7RQ6&.I)X(O80R5^47=+ K-:9R)LB@Y7&Z92LR?3HQ(E%'N7I1Z*,[L&5$W)
ME-2H2BSBVX-RCMS:8^LR&9W7%?HF;8V6%M:NJIQ]Y;3ZL2Z2Y14_^[!W]+ZG
MCM^I?1 YI\>'-WA!?L1)O'G!3H]3\9J*6FS%;YJ-.-#A4),+321; -"3U_NV
M#HU@2;S0QK6Z=V"BL$[]UU078DB>#%>#$+F]9ST;>RS 8BEE#&)7<ZD"4Q^
M+ZVWLF['+LV(=49B96FA+0-I!35LJ-_Y>MK57N'**QX3J?N%6&73-1INUT7*
M3;.=39OYCAH,$TBI1&\=M;#0J^MDR_,%Q"%?X1W[>M$"2E%3]3$VDFF :]\$
MN8J:N466S=*6G>_?]"BRQ9A2UGXJ7[*YT.W8^EIN%.;MY%YB-4RB)2'+F7'T
MI59D8/<:=>ANCF_0/#[;AK*V_4"5LU0TVK8+IRGM(I#J(*;>'LF;>BLI4XM/
MV@ZC;YKBFE2N+"SP5J/>(M/=^OU,4'7ROZ#Q7+,@&8=L>(QTA7,'5+Q7HAVN
M*\I $ R #47)\7@E4W12K7?B0S";" %*/1B37DI#^RJ'C7*1*OD$/M[[MD?K
MTOGZ^DUR9K\H6<1./=4YKZA<5+8)",YZ=D 7OXPNN0J+*U]LX!9\ $L.>,3+
M#'F<85P#Y,OQT4$?PQQG*-S?]HYZ[_KG9TN)<?S"XIXZVH$13@*5V:*5L\XJ
ML_4!?<=GK<:1^&^T/Q1VCW9BFYBXT;_Y1EG95O<\FC)A[,82*)%D\UO@DK'J
M[!*-3\Y;I:GH9'W(074T87B!V-; 7"/ME??\HH>E+]"\W53,%!M5Y LAVA-7
MK[&A;;PYM!]3;[H2;:\#34(0G<:%$>:^7S0P;KAP41B_ IB@ROGU>2IG0J 1
MOWB"[R=?@N7Z"X=@3BJ>_AI=]D*_NK97*=JBO#RERGI/?$R/E^)*K,]J<X&#
M[GG)9#6\:IUB7?5?-@!U0)5WQ5(D39#*HP6B^KDB:M7 C4>\K^2VS/S01:V2
MW*Z_&$.VHY(Y\"YIU090$@XBU#YWV0-O#<NFLS1@$G9?<JS/ENYCX$3JDA:P
M/RSNW/X"'^/Q>7TFN(>J1455:'JQ[1YTR'IZ+7S#>153 IRW;-VQB5W$LB>!
MB3=,TJLVQN 78C-A#G0CT9NHM(;P@Q\U+VS]0=]U;4X?F,.N/<)*_9&T4L&U
MXNV]KA?Y/=_('?8E)8_/J^14Q]LYAJ2_(  H=P7>&SPO:(VDT=&W-#1V_*K6
MSV#KN:$COWF58W1X!]TE0"VTL W;!G,.J,JMCL,K8C9X\4S"^PCQL-& Y8"M
MNTS"SM-LX<[A=49T61R--1=$POJ!,,,DF@;TEXL2V$_$D2UZL@4?MI2W2S'"
MAO_.KRGKE;@D:FV6"ZV6AJ(&%,)@1]7VNY>+6NX&$J.1J>PY>P.5.9O]/ :^
M64*S7>^##$VSW/:.OH'/VB0NT^8#G!LG(#DE%Q5H-QS_&Y;5[536]1!<HERC
M<WWE8?QQ=XUB8N= <GHJ5T>ZO[0V :C&SH&:Z(=+-:;Z?RS)E#K9^Q-!80'<
MD_YO_8/>T<%9H YZ[WJGIWN'!!W[O7_^X</Q(2;/+,6L>BF8="E1/JC@A/DU
M?VKZ5_P @ZL$[7=F(8D%5H6(2M)GQ>9 +*XIB2Z,PK9N]KP^(RD098&2AF%C
M1=UK"D+2.:U2I/[C*T+:,L:K[+B?K2+CP$""$HGA^'S ]:])KQ(G;RJ=C[E(
MF*G/"Y2$NFN"#@II>!'Z"DZWPQI.F^]9>AY["U@1Y,]8O]#D8&0IJ-R8K">!
M0_+- 9%1=\9JJ9\6'P$V,XXP@X8 "QI-?8=%(^6\TC0>C+NOHK:5Z/M[U$$$
MEI;HPNI;NTJB,'?$=,@ ^<G)X"&6-)3$/:_/B_$&&/5YJHL)1JHE+,&R#K2Y
M0%'"(@80J>G"R+2!0-OX-EV*?[1M].8H+="L=\$['T[ ;C7>#&[1-DQR;B\*
M#HNE6>:FU<4B4#4;GZ8/51V[G:<U!Y\?]!&_F@='9O\%1VVD2))URY@^.15(
MK/.(^MG@SF(R+2_:C2#RT%;\L[G?=V#D>I8(0$.-RV342(-)K>)4;X5GV^!A
M;11KMYE.6+@X.F 3-W!NF'H!"YMQXT>;:Z&*^T=NON18S(%IQM)SS5C8GB57
M54X)V M:&DI I*VABWEIU88OK &(3B"4XII^M?:%:?X\1T@#^6U)^#/)E EB
M]V%YKAD+.>R<VB!^W,+E.-G<9C_L@TU<S& ;ZJ!M2>P[KJW)]&<<#LLI5MVM
MSF@2"TQV%1.&AYZTR0:8>XZM< @_F'"I=.].^DN%NZ/,0O<D"0ESE8(J?-5T
M1+L6F-SMB*)6\74:7U7;"VY[,::3C6S3IL[4O2)>D[KK<-)+\)B_Y'C( 3;[
M!IXAGIUZ9K63([X7+ZB!FBER%E/-DK9@(+F6_]0AIF @T&2H,0DPM$'Y;J?9
MHP](-HYTR0QW0;M17-,T_&Q*=8RCV(8C'?L)U56&]R*A0E&7*2O2KNNE_^8&
M8"(F!G%/K\XN'3/D@X9?RT02,;XST""7R9=5L3P)H]<8/*21NQT^%<'\[VS"
MR$!R(YAN%,YS^3$-S#:J-_+Z5[RM9I.S5NCC2&C!G8Y7>Z'1$M3$J[^E8V>U
M >BW-1#=,+/QLAO3M:W9MI(R4WGQ#Z^SIQ.O%Y@>ZCD5KD-S^".LH@T_CD]1
M9.]WU_'2H7JLEUBP$5*L9%X->$8HLT;UCI=!MV,JQ9EF;.RX/C.-$<.Y[;/)
MU4^((]1BJ7/C%W+EP3"S@_)46%L?:\R6B['KI$F(BX$+Q52Y"<NIA%\J_3PK
MZ3%U=MI8@O1.]@<P_9M;=K74H N^MS^64&3H^(0 :]UO[6#V7>2[M<GQ%&F?
M]>^%=218&!K5Q>%,6CE.1<%F,+=5KPE6Y.=Z=#M-5)N/K>HGF"K(2'<<Z_H4
MHVIRD;5,;LPM6M@5? FZ#[R4;6X9*9K:"8;(W5NYUR!ZMV.BZ'6S<4&P__XM
M*#BO'3\H""M9>'0WMC8VK9RE;$TM+VF@F5E+4>ML1#HAL<&:--]:9L&R/Y:6
M6G/:.SL_[>^?]PY@TN/]_UU*D'AK:V.KV[D]6W.MVO)&AVZKQ[5T[W9$P<W
MV2+5<<2M:7VQ+P1WP3>$F.!0 _^A=%WM$$I^!M\U$X:86!/K"TV1(U0P7=Z'
MI[\2%"[*J16U /'*S"[&ZVB*PI]M9),'8OZ8(0@HJ:"[N,I%2%4R/)B=2W6P
M>;!V$;)4M)3I"5 @0'4=>=!BK3W8%TQ _6%A0Y1F<ID6QHRRMJ[8R;X*TNT(
MU#9??()<**[.M!8GY-OYK"/EJSP,M_$C--;H.Q3N7_ILL?2Y,7^[%:M(.=Q2
M5N0F,A89U$9;QBS%_,ZI5YO*$%*KXNDKD<OBNTMCO">]TW?'IQ_WCO9[ZM/1
MLK(>MK:_CO,V/"M+T!ZVF=Z/"!.YP-$DW4YJ:#&J;XH]GI&Y%A/*CJ_";ZNX
MSJ8?R8(YG3^IJ*HI(7 @++V;9L8/,M6:.,Q82^88Y949-*>  BKSNIM84>!\
M^.B<&9UM^V*SW.B3"_$NF!R4^/G-.$S!9=6PH1E,11.7,\,<$XT++J32#?UX
M*83!99,J)7L%2IC,V]R"/L*ZXF=S54?(0VL?J8V@]KAU@5K#4Y"RG?P56S3K
M"FN9#>(HGXAT->G"?L$];V98:ILOS<QCU\6@>=1HKR=4Q(;7X2N-#D*<:!QS
M:$BZ,1CYS9-\UGI&4M(V8:AXV\3)@$5<-%RFBTK.JPOCP,W+30 ,.ZUS)H])
M^C2(&FH?PI1'D)I&Q4H9U%X,J056/P-38VU +9;28=CVINL'+-=BY6[[MC"L
MY'D9SC% =#IRYE$X]U)\&DS%.<B;\H5T;WF!0E5-<J_9S/269PM)WJJYPG+Q
MXZ6UG]L7XIG/ILRAMRBOM_IT6B81$UL=JHRA R_?VU^@K=,39<5<K>UL2D3=
M<]RW3[T,C7.;G:CGUI>T;WU)+3F2S:-LR[A;Z ZWXMJ69+?2S8NK;_!Q-?^W
M7^<>+4D4-A)#]1;^*D<7OM-!HAZ2S5%&,1<L^!C&8QWFN*V@P<9E%K'AV/9B
M^\?$+MH5J?M^C\\\/XQ(2K9Q4&D7_AU-D>6['M&<7F&C.VPX<5J9?3-! S/9
M:BR:X!V7E*\@M>L6 [6]KI]:H.!TT5]H:^0VD_ROSS01Z#@WB:D4KTT3T61V
M:T6G&O6B6Y7-H$U=J+@-A$.%<;?#B[%'Q 8H&I_B=:]I!9RA)>98VWGB:P.5
M#,.#>2/)"$-9F&X%Q]:\FO5C]\+^ UU<H2_ (X^:LGDMA7BY?K#(&4=JC>+<
MYL-=FDFX-)OP^/Q#[W2Y:?!;.V(0'K<'R1NER6I9VK8DJ+#_!:.T90>W-<$H
M?$$B9I%-G4.'7,BI7;:O?<T:XZI2?J[=S"/Y2L8=W$).N3-T:N?-];!$R:US
MDQ(;(;533NQW^#"^]SV1%7Q< 7+=]N686BN8.\U(I07M1<EQ+A 99@>I P9P
M@=\8E7;F_T[9&6@PCR]UKAJ%:G(I CXN,T'?>< O- ,<M,B6D/9LJ*6&'/_H
M+ZVSR,?^&4):]XYZQY_.U,GI\6_],ZJ;\:WK^3[J>\IAR$](+#D8B!JK=F./
M!KA6'A66WM\S^W=3E:!6W!9%H# #D7YC+N]ZJ9-(DYHE5W-><4AV.XC.+++2
M-&) L5HI;.PZ%QG)QE6-"3TC[2#FIFNEJY*PA%O]U/=MT7;?4Y**.])IF _+
MF%I,8R6&1)<%^KZOL (-UAXWI32<><]G1<=/BE1D[YT=*U \#I[&6*/[).'Z
M/+8[!B,U$]R=I_F8C#OFNYB)7,:A\6P9E"/=\+A$3<"F%?-'_T?+T'^?LL/H
M/:%R\/T?AE=/?M-):2.0IC6*9]]94J/V*.QJ,FE ]1@C>< E@YXB.(78;Q\Q
M2P.$BI5ZW<X%UPM"[TEF(;@PW1BTJT*ZBN35&A[4]8.<6Y(X;W*8/<03TT!%
MM4:7YQCA;50WWY3O<(VA*$D?C'<J+&RZ?*G]*!N6H,/NP[KIR[-B0QVF)1S1
M/KI.YJ:>$SZ,RB1%#V"*',MMDE[8\MN@VS%GL93K1H;LB2DUA@RG3R#6:KT?
M=SC&TT7FB,#U!(_MA0+;<=D.W8 ZD E9^TX+:Q_P#Q&[AFUO+"W97%7/EV %
MK*P&W@>WYC&>%ED3-XXQ>[.5M*FAB*(^X3#GRN_UK7ZO"I"+O)F(W6?R\2+'
M7D-;>2\^(#SDFTP1,X>POKG*FHBV2@D5$Z:3FDOU)5BTHT2_&^38YJ2A=1/J
M^+$9G@MAYEY=X,I"6J!%5,_]4JJ$"&P#^V16\M*P]SCUFY%<RY+KQ.9./7=#
M<C$W&U^'S?&_;$(WA7)-BZE)]2S004Y%\/RC]705LVM_5TOA5,^D=G'/=H5H
MT_U/3-3;O8^!ZVU!W@'&;%6*)]:;/C6QKS4H$ID4Y&6PJR'WI-]0$676H&I6
MV,Q]J5JDM7D"5 )J=60S'/%1^^LF-$HXH7'?^V#9=:I<!/0Y)+!]#N8DZ!?=
M3IAE6 J'N)_UZ(C+QLMJJ4I'47]<Z1X_N6<@!"6YFR1I_:F]&9=",L_)DC^5
M3-*<[[RTM1%O7XN/CMYMDIHV;[DIS2\UEML@^14+F<$T2&->:3QJ8F,<V'7?
MH,&ZX_<R"] .1YZ6HQ=2H?!*B,(I R.#NS5 H7KW( F!> BB1F^,BCZ)_2^X
MB&1M[+! 5#'*@4J-,(- =O6P F6$2DPULFLMF<*\%COVO)1)2^*<C3)4"ORU
M8CCJ7>+N]2W]@F^)5S",$"M-I41:HGL'6#M-WF -SF- 7U:<C=L#A%Y7$Z[$
M!F_!)DE).-WKE&OAB!ZXP#JIKYW A7A]G(U-*;&;E4)N4ISO@MLEP?;1NY53
MJT$I8C28FWP6/6JDLV#VIG5YVTJW4FNNI:,*O71O%2;(2KT;7>J@!#O:>]!X
MY]_:;]/+R>B/D1,Q3%UV:2++_BH<4 TO1B/X<%WW2=6Z?B-4 ]'#S$OI=BIO
MQ2N6YDO,&XNF77,(-U#14N3(2Y(CGQ),!(55XNH6&LBE><KH:4:TUAH%2'E0
MY","&6"%0E "=#'K'5X''O"23ZOAMK24<^3Y.:SEBT]:X9XC\_.-7R\RJ*>\
M-GSC(=S$,D? H[!$!MOXY8(:765Q8!X.?H"1W8NZT\M[RS0F6^X%:*))A9:J
M+BG$HQ!SSJK."'A0_A+"11^5?"NXP#@\-(EFE?"-U\L.+?;ZL9#E65406;YP
M>]8Z$Y7,130^I2DLZ@S6V>PR].J5<DTC;=&PZ0=>D4*0;CHL_(8:KH4I)I.1
MU@&;-WG*C-5)LUK^\')DT]8F=?I!GURE,&2E<P^=G'FYE70T=PZ<5QTS[V(;
M'NQ:4V@37S(VU&">)X]12?T,X6WT*'[T>KNQQLZ1.$0C$:X'7G5>64!09<6+
M/& ZH8Z%Y'F5"$#+6MT>L38Z\P!,H11O[W7I;:^?O#T^^!.^_'#^\?#-_P-0
M2P,$%     @ 0XBT4@)F?3/^(@  BK@  !$   !D,3<S-#4T9&5X,3 S+FAT
M;>U=Z6\36;;_;LG_PQ6C&07)!,+2-)!&,HD!SV1[3NAIWK=RU;5=3;G*4TM"
MYJ]_9[M++4[HAL11OXQ:0VQ7W?7<L_[.N;L?SPX/WNY^' WWW_9[NV?CLX/1
MV]%OCW:>;#_;?<P?X?O'\H#:?7>\_UF]^[!W?' \^>7!OS^.ST8/\ ?5[\%S
M>SHM=?YV=W_\JSH]^WPP^N7!11R5B]<_;[^(TP<J2.)Y^LN#1,]*>FOWQ#RV
M#/)YG#XJL]7K)ZORC9+/TZPLLR5_-<O2\E$1_U>_WG&?9\$R3BY?G\5+7:@C
M?:$FV3* GH8'XP]'OSS(X_D"NMI]]W;T=1%/XU+AS-3NXW=O=Q^?X-2Z1O#T
M^0\<0DAK0F.8C,9'IY\FPZ.]D?HP.?YTHH[?J^'A:#+>&P[4^&CO>')R/!F>
MC?:O&^'.TYL9X<G'X='9\2'T>+SW+W5R,#Q2[X\G:G\\&>V='4].-S6N8:&&
M2YU&.E)!&JF)+LJ@A ^CV4R'97RNU6%P^8]T6JS>[+P:J*=/GN[X0WT,! E_
M"WD"X=%_NRM5E)>)KL] +UL3P*]6P5P_FN8Z^/)HJF=9KE\'R45P62 =[WZ<
MJ-/Q_\)2/'M@FJ03\OIOK^A_#]2_Q_MG'W]YL//DR=_M_/9&1V>CR5T^/O>T
M^]WC^O1V.#D;[QV,U!@&\(D&T+UQ-]7_$>R2&A[M]WLGGV"/3D=_=ARE_EH^
MBN$0IN7KYW__8^-ZN[,-)Q(&$RPU=K^MSA9:I?!)93-5+N)"G21!JN#?$G[X
MQ]]VGK]\,]%Q6E1YD(9:?<BS:H7/ A_(XS  FDO#+%]E.3&"DT60PD#5:9F%
M7[@I.*3]WGZ< X/(\F(;F_SYC;K]>3_%>9]4,-3"F_I>MEP%Z:5:!(5";C9-
MXF(!$W%+469*PQ1A_G--B[( 80:/JD2?ZP27(I+)J97.8;9+6JCI9;^WU,NI
MS@M>6JW>94$>X0>[&N87&<4 WE*K/#N/HSB=JU#G91"G*JO*(HZT[:=0%W&Y
M4)&>Z3R'L8;PMDZ+H(RS5$V# KZ"/[QV<<U_>E.HH@I#713$NZ&;>0X?>!G,
MIB]TKF$,@<?D<\/D885X;/ W/@<CP]^+19 D:JJ5-D*@WZ/QP8LK^ (7,%AF
M55H6;L@P/EBO8 :'HRTR!DI_#?6J5,UF3K']+.6G7VX_'ZB+11PN5+!:)9?X
M *Y4"8/"U3OQ-N-3&D/O<R!AFDBI<,M+H!%5P3QS6BM<@FVU2<:T*<ZT/WH_
M/AJ?C8^/3OL]$"<@#0]/D56IR:>#T2E*F#WX[6SR:0\?V@C?>LI\ZX-.=1XD
M:E_/8MA3((;"G>59EB39!>[]199'0N:+' Y$@92B4U7AV8A3N]\#V/\$#D&_
ME\%7^45<:(74%L^ M25 4Q'V@_2:RY/T:@@CA<FH,-%!#D^YEW/]GPI.*?3'
MQV(1G#/3<&,3>D9E::F#%+XJ7C?9H5N:GV!E&EI%:VD?O.4308V@^3!\!^0D
M3;T[GNR/)H] #SH8GIR.7IL_KESOYN8\4-S,+P^>/%![HX.#D^'^_OCH@_U\
M>C+<,Y]]'8O',V%M3/VB'GCZ&P@5X"6O@_,LCN3!??/R\[^[29WM-WY\ ;K;
MKT+&L"B6I%DAVPH>^N_XO]7>\M=;U9=8?>\I>Z,:@\)C'H;(!)E<Y4.32H0@
MU!RH(T5VO8!3DR^19 V7^'7,3(KF"/\WP?_##:^QK7L"^@X"FMY1 IK-XB0&
M42PDI$Z"''@I\J;3:@I+$0?Y94NC"!H_!N8UY(XH!I-X&:-4A*:GT'X)>DMH
M7EX%>0D,MUC$JX$R:AXPW8'Z/8NA#:#2LLKU@(1Y*HP0U*42FD&B9?'LC<<\
M2*3M#^PB17ZMD'W2JT#VH'>L(_5[5OEC*#V\FY1.BK*3Z]?JS?<<\8;I)+J;
M=+*719XI-T:FD8)R. '#+*V0.B(R:W=>_?S3 ,T7WZP![L0&BYKE8+"2,0 6
M!/X[\+@4VDMHP*(-5)4:V"Y\GZ,9H]&PP#<6TE.<ADD5:581<SVO$N*59#4M
MJV1.1M2JRHL*S!#_S7LN=[/4J^\J]2Z78 >3JT1$.M!6F 1%D[\9^SWD-PIR
MKA@:U6&5@R4$O<5%4;%]8VUFM-.S6;\'-GVW%&;Z=M3(O^-9P4:JI"2= <X*
MBGHPAXHPCZ?<B=%(?Z/S5+/-=W:V=YXH[OR>NF^6NF=WEKJ1E)BPO]V#B KK
M(1!R!D1=USB[:!:-)^+.H$F6P%5C,MKIVYE"E\^T*L!^AP,%!P"ZF^L<]=BT
MR)(XDG:!(X>+H"!) 4=/PUO0N#7I[\GW9LEW?C?)=Y\\E:!,G "19J*,-K[\
M ]9[C3N^V'ZVC=&P-2KK7S1*=D_JBSM*ZF)5&;="5 $/U0E\)ZIR +0+9,W1
MC'HPXV*1@9X0:J#XPIIG1EUYK^%+UJX7NM\SR@70H\+H"OX#[14Z/X^!I;/2
MT=4)C@$[@G?2#!T7\/,,7LFQ";U<)=FEU@V5R7HD6 Y8WTEQS\]OELCCNTWD
M/FTZI9NHG+6&FK.>P@;DTUH%E\$T02-/A4&Q0/+R]??7Z_CY/5DYRMEY]A>C
MJV&:5J -Y!K#M$ D,V)X69.G&=I36^PBX"@0OU, 9<41ZK*.UR%AQ64)/ T4
MTS@O'KZYIZZ;IJZ[2%Y=%+'4FH1Q )_2B PJI+HW]-B]%_2FJ>0NDLG0!EX0
M[X RK 8(\9@.2JZ!B;$0&H*T,!^V4B%2XJ%E2A[S(AR/,+:UNAJ:[XY840<3
MOK;[_OCHS-H)B[C4CXI5$.K7:7:1![!B8,(_FJ-K8'OW,3[[]EY/NU$][?<[
M2,FDIQ42AC3FR&IQ62 : ZEI"38G_!5F:43@#PXP#@RD(UO%*7Y+8<[_@&B.
M9S'8,%%&! S?+G44AR!V^[UPD15@I-?]H@,\"C PZ"5!(!8Y/6L2G*R9,,CS
M2SQ/657ZEDQ4D1MVW=FXMSQNEJ*_W%6*1L@<2.<1\-WS($&2$G=2QR]_UJ?T
M<OOY6I_2/8']& )+[B:!.?#]O@6'8#PT@D] 0T'IP=T:05"+[60\YP!=+,$*
M49[PG?!&(,A<+[(D F.EWVMX61C@L:R*4F5A6.4$V43(:JK5I0YRQ>Y'!_;D
MUH&'2^OWG/$6"'=Y-PGW/1BWZC#(O^A2_1HDE4>[89(5R/96.6J;),^)#O%/
MW^]B@,[8S^<L_R+?CKZ"Y9S.-?X<]'O,//$\4!A)M(5@6E ,'_4"'D0)*G$1
MA!RUSX3=\FOECQT4_IP$<&JBX%(9/0;; RG )PE1TM 1Q[GL0+;5>.9.)1Q6
MZ!U]HDE<E [V;3KN]^H]#U1KR1U\^\)P"E;8(XUR!H-GN%[S+(O4+$ \-@P'
MGD9:MNXR;%26\)P:]=<F91[$HR>^)"VS>0*/7C$HL I^-QCRZ'=@,TN"KGE(
M=#\0?2\!;YB1I'>3D3"BT<-0N+@Q$Q^*-4EF63'ZT0\M2TI*4(BT)/VJL-CO
M.(5SY.M:SY\^W](/7< AZD ,,8$6\,Z]<+M9FLSN+$V68&N"EF0(TUF1&,S"
MA"/TT!1DHB(AZ22>QVS[FCR")9D$0&AU^K,1,6BDWVLGNH0@/ C3"VS3LT\%
M='Y/D#=+D*L[2I -,C%4N;A<H?>P)!]+MSX#PC@+ R$H I ;TNY.-.OW@- I
M!:>6C=:6\\Z:\#IC+80 F?([N2KOR?9FR?8_=Y1LP6YE4J4<Q3^>,'-5OLP]
MU.8O2LSYW25F]5D'N6?IHM\O"G)RE]PG,MPP711WDRXF('Y9VS-X6?/9IFQ9
MB5N#%-P3S T33'DW"<:ESGV;U5NX5+OOM7QG/]+RO86\<:K[<$SQ\5;6^#A5
M022A1$F!"*895C"(W*,#6XBAE5;>2BB'\5^BW\JMH(3F8<G%K3AK5!NXW5Q_
M5VS 51OHWW*]@_W#\='X]&PRW%@U@6?;.S#I-8F&K&(&T1((H"AKU2'^I](%
M;V.<GF?).:J>GMD^@*U/8><95H&O42+K"L%>[.S,5;;2N?5\6K*Q#L_<5,@0
M<I3XR!!^K?E-BP;L @@-NRVR!.N$%"%T2=D-MN$P0QA( 7KR=K_G)HOTFDV)
MNDE[#B+"=^"A+HH8DRH8[1%C\H]>2GAHE2.6EJ/A,)\"QX-N:(*'8& \;09W
M;G=WZ<R/OB((QL(\DP03FXN2#["6'S%KCYWM%D-@]H= H4(%_I:9PC 7,:_L
M-,M3W4 2;/1H_[JIDSV";\;OQ@?CL\\;.=;/Y5A[ZI+L_B@ VJ[YWT@X-CP9
MMA+-TV=8B6;GI1P?K/<18T8IQSY:^AB0A1>AH;Y@"AC=1W@H]C;588:#]: D
MG25P&AU/C5<PH;Y7IMM22[<$K)]J6$4R@X4GI%B<Q-H:FZ3%C9'BR6CR_GAR
M2'72/AV-STXW0I OA""/*H,&:CEKG?0I,\0VI>L?925-- Q3S,@4,#)<B0D'
MF3$648('=EZ\&#QY\N3/E3;ZSMDS'TY8A40*GG"N"/%6RJ9:MR#_;I1^TGBH
M+$D/&F>P\[3DIB]>*\(NM-<4V'X2ZXKL+,HF)&U6U#7\UG.@=R:X8&9A\(4P
MN3 I3#/! D04*749+.HB1TADRGDU5*>+Y06!-*3DD,-<6#P:QX7M]-),)0&K
M) &+JWV8)!(,LX]G.RYF3)'9."]@XA1D]K0-7$)7GH-85^?4+K(JB;SJ1KC
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M7C*XP-.1S'E;(PDI287.D.,2^$B#;CT-N;E^C%S%=!G@ K3P75F@-33&:R>
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MWD@2Z71X+G3"BFF'=]9)2B2[>%:KFD:QJAF5'" VQ<> H?<:*ZBQ;GE-5LK
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MV50S8!HXRA!?-J\QX#:F#@QA29C%" U'3<@WE HPSG%:7FC8WS0SAAV\X]_
M"S30K"!7OWJC9@)O9-E>D%1S'B$194<>TPRB;-7V#?HW L(*\*.@ARZ!")KU
M<N4,7#%W1O,8_T#7(2TXDYFSN>&8N!';O2$/*;;C8D.-G:*I"#*;-5X/-@+<
M&Q%*Y]IZ\>I7,Y.:/]>U@(0[;$A!(%307XEV#47'BC@G'7@#^_H3U]^+JD96
M:;]7CP]:=[/-E[3.OHC>YMHM9%(0?D2P.*LJ1QO'.H)$?[Y$B"(,IN%M$"@0
M<DA2Q)O^!7;Z<?NFY(L9AC0U< !1=/Q*21;VIJ^+C[IHIMRMY]"T'5 ->:%[
M EV C6\(RV[D3+^D,[TOR%$YC.\<[MLKLMLL1^7@IIB>0*IBKCW,>,RH %NF
M$0U!4Y4FXI*[36>.J_'&.&7_"F;$FV^K4WS#QZ5'WM!MG/\\^\+ >>/,G%ZV
M^@+3BDL->>$/@OWZ%AWHT#$GAF*93TJ@X,US=;Q!!25< ,K#0B<-GX9UB7AW
M4I*K8\T4W"66;#Q:1)9=[:BQQ#5E/V%]HI43 &MG,<!-Z+\%/)W7T%JBL_CO
M=E=FA4V5))FHO3J2!6 H/=*4JQ%]OP?O>PG_9ZK6YCFCG!'AP'$MB(.;7\,=
M(*0GHE"DRG]QLRIT'1",(C(M;SG/N /#62R#,!-0'WA'*,15HF.LRB\=A*-P
M>+A(M2BY<0LO$*$,#1,-!LZE[M7?09_YI2U((LJNB9_1#ANM-7<U"#:S>:_(
M]T@I\,[W>&2*'0QLHCUQ#UNYOUE06?;,I=+7,NR]O'JY2(U3?\18!HMI&R0%
M%5FYLM?:^?1"(@QI((=:4); 8$U0T#C6@ NAAL"J/D8#ERO"HMIINP&;T=8'
MR\XZHY]P$8#8\/CB^I&C19M3KAN?Y16R<HS6 -%:B\3:$HD^MX+TR@FQ#8/\
MW;O$(,6 #95LR6*F/$-L'+O9B'#<>:+H1A:)+!=D]"NFNV*MM3B-&5-)$HR!
MH%5N\5FRNC8::AMGVY+;;D6X3%K]E @/?U[C]:U=0D&Q&Y]>?$"6Z+08B/>I
MHND<-E+#U3&:5@5>'MP*WM+X4Q&TM7 \#\$DMTQAO!7[@5/DHQ88Q'T"IUQJ
MOUICPQ1PAE;AEX2]]X_\.++?$?MX9#WS$V(43D1:1:Y];>2Z,D]4,T:4NWI*
M(EL-3%]^6703T.6T.-(?!:$U$"/!-['GK(>A3\[()^:6NFR2*LD*OMW$-VT(
M@>"5:+'$+(W X3N/\]+=;MFLRF@ND_%MIS;9JHYUH$C%K+*!=U0EPXIO"L^6
M4IARA1 ;T+5M,N:L*N$9Z$]TK:^E51D)-<DS%*P-.G];U7?L/MJJF^8T._W&
MFR4[GP:>\/ KV/=[<_*'>$7L^1F1"FY2LE>"Q<_RKOTQ&-[&)J59;F;$QCWY
MP#"MSA(K=>J$&D76DB"FNR,Y "V84FA=0*'=5+()U6;GJ:2'MF#7IF(&$<A:
MI8;C!"6;/0V@,R:)=J20EC7R$16%/'JY+K,!A[J"6HVG3%SD7^-EM31O>EF*
MS5LKIMZ%25UN5#[.6!3&);Q2_SCN=FW4[HD,NF%CDDK&%5^SJ^J;&WP+%ADD
M2N:82=IJHE7:NSE .W\<DX]T0(O*2VA7Y'RT-<5YL8POUB55<*VB>-9&3CC<
MM'<E'&/-\&<ZUG1W4Z@E8<_+G35WK,J*-J^$@R7=C-I%#OI3C-C4:I;7P 4M
M6'@'R9'_*$XLBXA3,*CBR-[TP&"# 3NOY3F!B<NC^,DI\ )C),:FL=8I%8<$
MBFOM.45RKHDCZ)0 2D1C!CK?'JN;(^8ZLAFA4QL*O$KQV7W\[GC_,WSY\>SP
MX.W_ 5!+ P04    " !#B+12TE0[WU<$  !C$@  $    ')G82TR,#(Q,#4Q
M.2YX<V3-5]MNXS80?5]@_X'54PM4-Z>.82'.(JTW18 DNW"\1=\"2AH[1"E2
M):E<_KY#2K+E2[QVO.W6+Z8X<X9G+AR29Q^>"TX>06DFQ<B+@\@C(#*9,S$?
M>97VJ<X8\SZ<OW]W]H/OD_'EU2WQR8,QI4["\.GI*<AG3&C)*X,6=)#)(B2^
MW^K_-OU"_JBM)V0"'*@&THMZD3\@OU:,YXG]B.,X"N(N3 &U]DA.#22D'_;B
M$!5C$O>2:)"<#,G%#?E(M0$ER)05T,7*\D6Q^8,A/V8_$8<:2R& <W@AETQ0
MD3'*R5U+^6=R);* 7'!.)A:FD:<&]0AYT%A]UGFBLP<HZ/MWA&# A$X$FJR*
MD6<CT03B.54\D&H>YD:%YJ6$$)5\U +%,J\#_3IN X.9L!*] ,ZH3AVHE6!\
MXJ$?Q?Y)W,&I.5U9"[\5N"39P$3]>-A1SH$ME!TI#5DPEX\A"K:;MUILNS.]
M*#H)L3(,QALZ$,[$7SL05IQBD707V8 \G3A /!P.0R==HY2;53\:Z_VP%G:T
M-<NVNXP"ZW*\X3+&>TYIN3415K >*&J,8FEEX%*J8@PS6G%D5XF_*\K9C$'N
MM'!G%"#,BLZJAJ%J#N:6%J!+FL'^6<7JW18\C$<<_GES?><*VSNW $)<K;.B
ME,J0NN2O9>:VXHZ<V2^_3;5OI_RXA_X':,PC8BOE5^J$A$<3:2OH3406Y;<W
M$?W:9K$#?UD,KW'8M='>'(WU3F)C,;2QB$_WBL5&)_H&3*2X/99,IYT>0FCK
MQK8#?[G#]TK/6E-X>XT(RC+7L0?UT!(9'$!DB3^V4CIMT>:EOW/Y]3YZ<!*V
M-LL0N-'MS!X[9E?'_<:,W,EZ(*6-T[CAY!A1(:1Q-+H\:5DR,9/-%$[:-I2T
MO6@",^).N82J3$D.N\_"L%2R!&48LEBVL]K @X+9R,/CPF\/BGM.TP /BE9C
MP_YJ?[3B$"' KY?L6JQAQH*OK9A8.=ZM*%^8MH$9>1J3PCO]];_UML1S\D!O
M$:+Q:'9)>]WISQVM_ZGO.<P.]1TA3+#=GH\7.@?[;=>8H@:Q@R^3JU<N-8M;
M36CHLQ2R>*G9C656V5M3^W\A\H\"6;U<X692A<N%1QA>?R:H?K^7^H)ARW$9
M@O,XLC]\_K06ND,J<E*;(QU[9^&ZD77[E8;\DSAWXXSRK.*+2FO C<8NX'J-
M[H]<S?!V7#/;9JOM7.%ZZVIF5EN<:W#-]=;E O-ZORL%4YK:6K%-%HOKZXIU
MB;F72*+QKBWF5P8*2]0CNDHUHMQ#[W<EJ[)6S$WR@'*552E89:Q6!\<I)O.I
M,YA7JBD@P3BW2XT\HRHT2M&FHIEIO\.W^8GQ=HOK?7SM*+_!7Y:P?]/+F].@
M%UVR9\BG\I)+-"CF$WRXWU6I5#F^N WD8T@14F&=CBOH1;_T;J!(0;6^'V6B
MCDC](D]R65 FOGM(^L&@?Y@__=.UD!QCXGN&I&X#]:4+/_\!4$L#!!0    (
M $.(M%+?D @L_@4  *$V   4    <F=A+3(P,C$P-3$Y7V1E9BYX;6S=6]MN
MXS80?2_0?V"U+RU071,GC1%WX<9)872S"6QO6_0EH"7:)I8B#9)*[+\O*8N)
M+[(C)<OLKIYBT3/#<\C1<#@3G[]?I 3<(RXPHQTG] ('(!JS!--IQ\F$"T6,
ML?/^]Q]_./_)=4'OJO\1N& FY5RT??_AX<%+)I@*1C*I+ @O9JD/7-?(7XP^
M@;]7UMM@@ B" H$HB +W%/R189*T]4,8AH$7KJMQ!+4]D$")VJ#E1Z&O!$,0
M1NW@M'W< MUK< F%1)R"$4[1NBZ;+SF>SB3X.?X%Y%H]1BDB!"W!%::0QA@2
M,#20?P5]&GN@2P@8:#6A< K$[U'B%58)II_'&KA:*RHZCF9?D%^,.?$8GRIT
MP9%O!)V59%L_UQ!?"+PA_7!D9$/_W^L/PWB&4NBJU9:*PY/6SBR%7GAV=N;G
MWSZ*JND3^2B[CJ;EK[Y4H@*W13[5!Q;GNU"! M@KH9]<(^;J(3>,W*/06XC$
M4:L+P#GD,6<$#= $Y'#;<CE''4?@=$XTS7QLQM%D+Q"#7MMO:<OO("$.* Q_
M&O1W.6,J_02G?B'CYPJ^/4!J+D3U>^ F: (S(NO!*U%_&[ LA9B^&&NA;1-J
M/H6;HG2,>$V<FZH60<Z4"1YG8^0^KDT]J*4&"L Y( -YVZ+&QJ>0HSPRYT$T
M:(5GOH0+1EFZ]'/S/19GRJPT?[LTN:02RV6?3AA/\RBP25W9=(VQG.) V;FK
M8V=S6=>Y* _'%&O9#^IQ0QPM)*()2HP1C=X&UQR-P4-8?)B[&K@[9&X$QT^N
MLR)"=&QEW P2.$8DMUS%D/]EX:E51GV)4O$E(*X9.PQSW>4G4(QSOU<9QQ3"
MN=H[M6^(2&%&7#WB!F%Q<KPKAN^&4F4(&LL%@4+<3(:2Q9^["UR)2P4C;\%A
M?=9>$3&K@R_3_AY1WT5OA)NE*:/YQ-=%Y*\!>U?Y!2_C]8D7!5=X@9(1NR),
MO3=T.E N.,S&C*O46WU,>FBL'#+C2/0R% 7'476PKY[B)91:WFFKWGRMDYJ4
M7C/%\YXEC&L)%'M3=N\G"*^\2GW8=B8U=+<*?0,TQ4)R2.5'F%8*\OMU+8#L
MJK"6Z-!V1>"T*KHM)6MK=Z&FX)#TU8F^^ LMZRW>CK(%F.:@&RE$5=%MZE@$
M=8LX9NH 3GK*\^NBVU*VML7J;LWXG/$\-\C/V0N6J8U;7K"DYMORC"EK%*XP
M01^SJI&J7,\:N!%<]!.UGWB"5Y?UER#=:\0:[&Z2J!@MBC\Z9PSK02XU8!ON
MA?IXPT?LH5*J<U#=-M3\_;CAMYS=XU6QJ#[>'1NV0=\R(2'Y#\_K!X=R"Q8
MZTWL<@3K0-S4L0!*5^K([8S1FH%J5\\"N'\XENK6KE/GC!8!IM+U[("R!9A#
M1G",=5)YK=R>8TBJ8BS3M #PEB.]#$B]BGE^H0LA_&8RJ;[=ARS8!]P7(D/\
M];!+[-AP!Q1GRO>6830>85FM?%.N9P'<B$/=H1DNTS&K[*9;2A;7['(1SR"=
MHCHWHG)=:R?.98KX5*W&GYP]R)ERKSFD-2\@>TP\0GXJ8W9YO&$9\MA8+0J\
M%?L3*YT)9VFM0EPQ-ZM<8%3W:<0[CDJIYNJ:H+>EXT0.R(0"RN9:,(^.>96[
M'3,JT4)>DOSM[#@"3?6'I^\)$RCI.))GR-KRE!;(ZRS79HV652H.5ELF2XQW
MNRSK=*O71]GA4F+!,3KZVB1-V\L"2UUZ?.3I!4'PE79TLQ]51O1 T94=K%(:
M>L??)[-7ES0-_]9WS/\U]4_#_^1;X_^B8VQ_"=7P_,W[!M_B%W/=*L@:DF>-
M(KFGK%N0/0H:17:S2FPX'C>2XU:MV9!M-8ILI1JUH7[20.KKY6[#\[2!//<6
MRPWI9AT]!\KMAG 3CZ&2DGU!][A9!]'ABK_A'#:7\U;+P#".&L5XLP-A.!XU
MBN-N,\/P;%9:M:<E8L@V*ZTJZZT8ILW*H@XU9PSC9N53S_=U#.]FI52[+2+#
MLUF9U%;#J2#9:E;^5-ZW,ER;F#?MZ7L9RI43I_/\UT-;_^VO?V_U^*LB]? _
M4$L#!!0    ( $.(M%*8^@BO(@@  'E;   4    <F=A+3(P,C$P-3$Y7VQA
M8BYX;6S-7%UOVS84?2_0_W#GO6Q 95ONTB)&TR++QQ L:8+&W8850R%+M$-4
M$@-*;NQ_/Y*2$MFF9,J\JO+05)'N/?=<YAR:^O*[#\LHA.^$)Y3%1SVW/^P!
MB7T6T'A^U%LDCI?XE/8@2;TX\$(6DZ/>BB2]#^]?OGCWD^/ Z?G%1W#@+DWO
MD_%@\/#PT ]F-$Y8N$@%9-+W630 QRGB3R:?X:^LW!@^D9!X"8'1<#1TWL+O
M"QH&8_F+Z[K#OEM.X\23>!!X*1G#P6#D#D2@"^YH/'P[?GT(QU=PYB4IX3%,
M:$3*N>Q^Q>G\+H5?_%]!99VR."9A2%9P3F,O]JD7PFU!^15<Q'X?CL,0/LFT
M1/!,"/].@GZ.&M+XVUC^F$KV\/(%@!C&.%'[CGIR,/*Q6$YYV&=\+L@.7P^*
ME-Y3QG(KY>&U2G /#P\'ZF@Y.J&Z6 'N#OZYNKSU[TCD.6+XQ9_+S\LD=)RH
M_9?,5V-H0! J(^1O3A'FR%V..W)>N_UE$O3>RX+YZ'A3$EZ*+5 ]C#D+24UA
M>5A5[^7QZ>I>Q)-E2N* Y,B/V,S/H^XXF66H4GP*,B%^?\Z^#P)"!;1[*#<<
MN>$,W9SGSV+7UQ,F5'\\35+N^>EZU5 .%./%3M7*44^3-%BG)>..N;^&Y7&_
MP!&;.T8ACQCX3/SU[E-'(1;I,\XB+8N\'-,<_!I.0RU-J2>Q)4U.8N?S[:Y>
M,Z!R8YPD;,&%R)K\@54_[Q4R?"FP_WLW>*K]7*B*B20AETWY8@CS+$YINOI$
MYE26B]./7D1,]:G/[4BFM8VPZA@;T5;C(6DW*P!/%4"6L%9P>[S+0FY*'D/.
MQY&8P<6_]#STYJ8ZWDCJ2,!ZZDQST$:R&B DK3XB@X2VUF@+1,OB-&6+-\>>
MB&+<"R_$"F/Y)UDUFV2WDCN=9:M:835!]O.L%A!WHLU+@*H!H@C25-L*=<U<
MVX _AK!/F;^0'IJ('DSUO)[3D8RUQ-GV,1O1;N,@:;4 !HEL+5!\FF5=&G+%
M%.,-X90%9W%P*D[>FZIR([EC>>I;835!&(+5 &(K-RL!H@;((F@B;H&Z5LW&
M_/&6#Q>QS_@]X^JBRFTJJIZPA9CM5R<L:'C&M@.JTZ6%69O,.,5^V6$ C[L(
M62L(JB+D)4'61%J3_("^-"N4_9O#L](Y#<G'130EO)EORGF=FD33 -,?MY?_
M)A:NUB4Z9/!(LL;FJ]&P$6D\N4Z\Y44@/G7HC&:7U/?1;B5(IT+>U1HS"+:7
M>"TPKMY%*5BOA:O^5EO16&&/?O",<1P$HHTD_^^2QL1M9@HM0*>&J&N)[0BT
M-T(E**X)<OQ7Q0;(2G =8ZUL6FM#8X ]>D$WP(G8O.83]A#O)?]R^G,0OZ8=
MG?2?PM"$OPG9DNQE&6 <9"%<R6,W4"=XLR[0Q:Y.&:[Y#6??:>PW//.MPG@.
MLJ]J3*?]C5@T VAQ6W)!=NXG!%14P[5"*ZW4^:%!/^BFN&%)ZH7_TOOF%X/T
M",_!$/JF='98BT0S@P:U)2MDE4"4PKS TUX;=38P[@7EL2K9)B=>$]FOYW3U
M4)6..-L^9O5(U18.DGS5)[]$QE$K/L^UQZD,R6+(43[S&-[<L;CAY<7MO(YD
M6=D TQ^WD:<>"TFB"AP4.M8%EG;XEJ7:A#2&7/_F-$U)?,*B:!'GEV\24\U6
M)'<DW/I66$V0C81K )%TG%> ]1+66FZ1>%G03=ECB/J6A=2G*8WG5V(]SJD7
MFBI:E]F1G&N:8%41-D*N0D-2\1,\%/C6$FZ+<EF_C7ACB/>&$^D5(L2AGLF1
MKR/PZ]G,?"E1A]"1F V:8KLB;<2]"Q5)Y*(,E.M 5@A4)6NYM]U$6?9[=M*"
M 2Z29$&XO0TT.,_##-4-ZBVQ%8]HC KLMNR1E6O5)2UU5.N51FVA+'B(OQ#K
MK)4[FDYH&AI?!]G.ZVJQ4]4 TQ^W6NAHL;"6.3DX"'10\/:KG%;XKJUQ&I#&
MD.N$>_)UW]M5-&7&2_.-I(Z$JJ?.- =M)*H!0M)GC@P9M+4V6R!:%J8I6\PY
M]&SIWXF>29.W(/6Y'<^EVD98=0S&G+J-ASVO%A5PWH)LC[=V?C4DCW=O\"PB
M?"X<] =G#^F=6*3<>W'#U\XJ(#J].UC?%ML9:G]_L 862?'Y3;6B$&25("^%
M='^PQ38T-P@;][)A!#[W'/EM&L,#]U )7>QX?._C. Z*A]IGC$?J.N/$FYHM
MA@V!.A!]LQ:98<*^!F@ CF2#Q_=M1#EX?('@L2!\427MOM'A!W:E?95HW]9L
M[7%)8W*1DLCHAD\#L&=HD^U6#:SRF-26738*_"C+R+*@ZK;K&^3V&GG'J$?-
M0JM89\V\9*KJ+Q)G[GGWV6*+A&E2[-E<=>6[OZJ'P"2WD]!+DNO9;<K\;\=+
M:N0R Y .W&7>&C,(WM=-AL!(+E+@P&:@X.&++&!GEQ_$?^W)EV9-M.*'<I>G
M+/*HT2/J==D=.J"F&5879:OY*L26Q)Z5P)%[6]3K=+Z3?SM*9U$DWZ,5%*Z(
MZ<-?-<E=ZKRR%5839*UR/2"6R!5Z(9&L )+$V^&]_I5PC<B;G!I<O>F/AN=T
M28().P^9)Q]R^"0^FFX74\8#&HO-X)1,Q0?50K _79#1\+>1N;"M2W1T&H$Q
M+,P:RN:4P[HLDN&N0!(!Q00F# HN(,E F0T\T0'!!R0A'(L^B_$H&[GU03&R
M_D'_[4&S$3EXT]#Z-B6ZLC["L#!K*"OKVY9%L[XDLI_*#]X@6K_K\5BW?CN#
M4MYQ*;;D-T;GNVCVO<EBS_]02P,$%     @ 0XBT4E:MN8RX!0  :SH  !0
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M/U!+ 0(4 Q0    ( $.(M%*0E]"^FQD  !P. 0 .              "  0
M  !D,3<S-#4T9#AK+FAT;5!+ 0(4 Q0    ( $.(M%)N*4]I8T8  $&? 0 1
M              "  <<9  !D,3<S-#4T9&5X,3 Q+FAT;5!+ 0(4 Q0    (
M $.(M%*,Q999/C(  $(B 0 1              "  5E@  !D,3<S-#4T9&5X
M,3 R+FAT;5!+ 0(4 Q0    ( $.(M%("9GTS_B(  (JX   1
M  "  <:2  !D,3<S-#4T9&5X,3 S+FAT;5!+ 0(4 Q0    ( $.(M%+25#O?
M5P0  &,2   0              "  ?.U  !R9V$M,C R,3 U,3DN>'-D4$L!
M A0#%     @ 0XBT4M^0""S^!0  H38  !0              ( !>+H  ')G
M82TR,#(Q,#4Q.5]D968N>&UL4$L! A0#%     @ 0XBT4ICZ"*\B"   >5L
M !0              ( !J,   ')G82TR,#(Q,#4Q.5]L86(N>&UL4$L! A0#
M%     @ 0XBT4E:MN8RX!0  :SH  !0              ( !_,@  ')G82TR
E,#(Q,#4Q.5]P<F4N>&UL4$L%!@     (  @ _0$  .;.      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
